Annual Statements Open main menu

YUNHONG GREEN CTI LTD. - Annual Report: 2009 (Form 10-K)

Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.   20549
  

 
FORM 10-K

(Mark One)
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the fiscal year ended December 31, 2009
 
OR
   
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
  
For the transition period from _________to_________
 
Commission File Number
000-23115

CTI INDUSTRIES CORPORATION
(Exact name of Registrant as specified in its charter)

Illinois
36-2848943
(State or other jurisdiction of
(I.R.S. Employer Identification Number)
incorporation or organization)
 
   
22160 N. Pepper Road
 
Lake Barrington, Illinois
60010
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code:  (847) 382-1000

Securities Registered pursuant to sections 12(b) of the Act:

Title of Each Class
 
Name of Each Exchange on Which Registered
     
Common Stock, No Par
 
NASDAQ Capital Market

Securities registered pursuant to Section 12(g) of the Act:  None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  ¨      No  þ     

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.  Yes  ¨       No  þ     

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes þ     No ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  þ     

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ¨     Accelerated filer ¨    Non-accelerated filer ¨  Smaller Reporting Company  þ
    
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ¨     No þ

Based upon the closing price of $1.99 per share of the Registrant’s Common Stock as reported on NASDAQ Capital Market tier of The NASDAQ Stock Market on June 30, 2009, the aggregate market value of the voting common stock held by non-affiliates of the Registrant was then approximately $2,667,000.  (The determination of stock ownership by non-affiliates was made solely for the purpose of responding to the requirements of the Form and the Registrant is not bound by this determination for any other purpose.)

The number of shares outstanding of the Registrant’s Common Stock as of March 1, 2010 was 2,775,623 (excluding treasury shares).

DOCUMENTS INCORPORATED BY REFERENCE

   
Part of Form 10-K into Which
Document
 
Document Is Incorporated
     
Sections of the registrant’s Proxy Statement
 
Part III
To be filed on or before April 30, 2010 for the
   
Annual Meeting of Stockholders
   

 

 

TABLE OF CONTENTS

INDEX

FORWARD LOOKING STATEMENTS
 
     
Part I
   
     
Item No. 1
Description of Business
1
Item No. 1B
Unresolved Staff Comments
13
Item No. 2
Properties
13
Item No. 3
Legal Proceedings
14
     
Part II
   
     
Item No. 5
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
14
Item No. 7
Management’s Discussion and Analysis of Financial Condition and Results of Operations
15
Item No. 7A   
Quantitative and Qualitative Disclosures Regarding Market Risk
25
Item No. 8
Financial Statements and Supplementary Data
25
Item No. 9
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
26
Item No. 9A
Controls and Procedures
26
Item No. 9B
Other Information
27
     
Part III
   
     
Item No. 10
Directors and Executive Officers of the Registrant
27
Item No. 11
Executive Compensation
27
Item No. 12
Security Ownership of Certain Beneficial Owners and and Management and Related Stockholder Matters
27
Item No. 13
Certain Relationships and Related Transactions
27
Item No. 14
Principal Accounting Fees and Services
28
     
Part IV
   
     
Item No. 15
Exhibits and Financial Statement Schedules
28

 

 

FORWARD-LOOKING STATEMENTS

This annual report includes both historical and “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended.  We have based these forward-looking statements on our current expectations and projections about future results.  Words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or similar words are intended to identify forward-looking statements, although not all forward-looking statements contain these words.  Although we believe that our opinions and expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements, and our actual results may differ substantially from the views and expectations set forth in this annual report.  We disclaim any intent or obligation to update any forward-looking statements after the date of this annual report to conform such statements to actual results or to changes in our opinions or expectations.  These forward-looking statements are affected by risks, uncertainties and assumptions that we make.

PART I

Item No. 1 Description of Business

Business Overview

We are a leading developer, manufacturer and supplier of innovative flexible film products.  We provide value-added design, engineering and production for flexible film products.  We have developed, designed, and produced a number of innovative products utilizing flexible films including: novelty foil balloons, zippered pouches for food and home storage, specialty films for packaging and unique film products for medical applications.

We produce, market and sell four principal lines of products:

 
·
Novelty Products, principally balloons, including foil balloons, latex balloons, punch balls and other inflatable toy items,

 
·
Flexible Containers for home and consumer use for the storage and preservation of food and personal items,

 
·
Flexible Films for food and other packaging and commercial applications, and,

 
·
Specialty Film Products of unique design for various applications including for medical uses.

 
1

 

Our design and development services, and the application of our technical expertise to the development of flexible film products, represent a significant component of our business activity.  We leverage our technology to design and develop proprietary products which we market and sell and which we develop for our customers.  We have been engaged in the business of developing flexible film products for 34 years and have acquired significant technology and know-how in that time.  Presently, we hold 11 patents, and have 4 patent applications pending, relating to flexible film products including specific films, zipper closures, valves and other features of these products.

We print, process and convert plastic film into finished products and we produce latex balloons and novelty items.  Our principal manufacturing processes include:

 
·
Coating and laminating plastic film.  Generally, we adhere polyethylene film to another film such as nylon or polyester.

 
·
Printing plastic film and latex balloons.  We print films, both plastic and latex with a variety of graphics for use as packaging film or for balloons.

 
·
Converting printed plastic film to balloons.

 
·
Converting plastic film to flexible containers.

 
·
Producing latex balloons and other latex novelty items.

We market and sell foil and latex balloons in the United States and in several other countries.  We supply coated, laminated and printed films to a number of companies who generally convert these films into containers for the packaging of food and other items.  We supply flexible containers to companies who market them to consumers who use them for the storage of food and personal items.  We also market containers to and through retail outlets for use by consumers that include a resealable closure system and a valve permitting the evacuation of air from the pouch by a small pump device, which we also supply.

In 1978, we began manufacturing metalized balloons (sometimes referred to as "foil" balloons), which are balloons made of a base material (usually nylon or polyester) having vacuum deposited aluminum and polyethylene coatings. These balloons remain buoyant when filled with helium for much longer periods than latex balloons and permit the printing of graphic designs on the surface. In 1985, we began marketing latex balloons and, in 1988 we began manufacturing latex balloons.  In 1999, we acquired an extrusion coating and laminating machine and began production of coated and laminated films, which we have produced since that time.

During the period from 1976 to 1986 and from 1996 to the present, we have produced flexible containers for the storage of liquids, food products, household goods and other items.

 
2

 

We market and sell our foil and latex balloons and related novelty items directly to retail stores and chains and through distributors, who in turn sell to retail stores and chains.  Our balloon and novelty products are sold to consumers through a wide variety of retail outlets including general merchandise, discount and drugstore chains, grocery chains, card and gift shops, and party goods stores, as well as through florists and balloon decorators.

Most of our foil balloons contain printed characters, designs and social expression messages, such as “Happy Birthday”, “Get Well” and similar items.  For a number of our balloon designs, we obtain licenses for well-known characters and print those characters and messages on our balloons.

We provide laminated films, and printed films, to a number of customers who utilize the film to produce bags or pouches for the packaging of food, liquids and other items.  We also produce finished products – pouches and bags – which are used for a variety of applications, including (i) as vacuumable consumer storage devices for clothing and other household items, (ii) as vacuumable pouches for household use in storage of food items, and (iii) custom and medical applications.

In 2009, our revenues from our product lines, as a percent of total revenues were:

·      
Novelty Products
66.6% of revenues
·
Film Products
16.7% of revenues
·
Flexible Containers
16.7% of revenues

We are an Illinois corporation with our principal offices and plant at 22160 N. Pepper Road, Lake Barrington, Illinois.

Business Strategies

Our essential business strategies are as follows:

 
·
Focus on our Core Assets and Expertise.  We have been engaged in the development, production and sale of film products for 34 years and have developed assets, technology and expertise which, we believe, enable us to develop, manufacture, market and sell innovative products of high quality within our area of knowledge and expertise.  We plan to focus our efforts in these areas which are our core assets and expertise – laminated films, printed films, pouches, specialty film products and film novelty products – to develop new products, to market and sell our products and to build our revenues.

 
·
Maintain a Focus on Margin Levels and Cost Controls in Order to Establish and Maintain Profitability.  We engage in constant review and effort to control our production, and our selling, general and administrative expenses, in order to establish and enhance profitability.

 
3

 

 
·
Develop New Products, Product Improvements and Technologies.  We work to develop new products, to improve existing products and to develop new technologies within our core product areas, in order to enhance our competitive position and our sales.  We seek to leverage our technology to develop innovative and proprietary products.  In the novelty line, our development work includes new designs, new character licenses and new product developments.  In our commercial line, over the past several years we have developed new pouch closure systems and valves and new film methods for liquid packaging applications.  We have received eleven patents for these developments and have four patent applications pending.  During 2008, we introduced a line of resealable pouches with a valve and pump system for household storage and vacuum sealing of food items.  We work with customers to develop custom film products which serve the unique needs or requirements of the customer.  Recently, we have participated in the development of, and are now producing a new product for a medical application.

 
·
Develop New Channels of Distribution and New Sales Relationships.  In order to increase sales, we endeavor to develop new channels of distribution and new sales relationships, both for existing and new products.  On February 1, 2008, we entered into a Supply and License Agreement with S.C. Johnson & Son, Inc. to manufacture and supply to SC Johnson certain home food management products to be sold under the SC Johnson ZipLoc® brand.  During 2009, we developed new distributors and customers for our pouch products and for novelty products in Europe, Australia and New Zealand.

Products

Foil Balloons.  We have designed, produced and sold foil balloons since 1979 and, we believe, are the second largest manufacturer of foil balloons in the United States. Currently, we produce over 500 foil balloon designs, in different shapes and sizes, including the following:

 
·
Superloons® - 18" foil balloons in round or heart shape, generally made to be filled with helium and remain buoyant for long periods. This is the predominant foil balloon size.

 
·
Ultraloons® - 31" jumbo foil balloons made to be filled with helium and remain buoyant.

 
·
Miniloons®- 9" foil balloons made to be air-filled and sold on holder-sticks or for use in decorations.

 
·
Card-B-Loons®- (4 1/2") air-filled foil balloons, often sold on a stick, used in floral arrangements or with a container of candy.

 
4

 

 
·
Shape-A-Loons® - “18 to 48” shaped foil balloons made to be filled with helium.

 
·
Minishapes – 11” to 16” small shaped foil balloons designed to be air filled and sold on sticks as toys or inflated characters.

 
·
Balloon JamzTM – 20” to 40” round and shaped foil balloons which emit and amplify sound through a speaker attached to the balloon.

In addition to size and shape, a principal element of the Company's foil balloon products is the printed design or message contained on the balloon. These designs include figures and licensed characters many of which are well known.  We maintain licenses for several well-known characters.

Latex Balloons.  Through our majority-owned subsidiary in Guadalajara, Mexico, Flexo Universal, S.A. de C.V. (“Flexo Universal”), we manufacture latex balloons in 11 shapes and 46 colors.  These balloons are marketed under the name Partyloons® and Hitex®.  We also manufacture toy balloon products including punch balls, water bombs and "Animal Twisties."

Packaging Films and Custom Film Products.  We produce and sell films that are utilized for the packaging of various products, principally food products.  We laminate, extrusion coat and print films and sell them to customers who utilize the films for packaging applications.  Our customers generally use these film products to convert them to bags or pouches for the packaging of food and other products.

Pouches and Bags. We produce a variety of completed film products, generally in the form of a bag or pouch.  These products include (i) valved, resealable pouches for storage of household items, (ii) vacuum sealable bags for food storage, and (iii) resealable, valved bags for storage and vacuum sealing of food items in the household.  During 2008, we introduced a line of resealable, valved bags for storage and vacuum sealing of food items in the household.  These storage bags function with a small hand or powered pump to evacuate air when the bag is sealed.  This product line is marketed under the brand ZipVac™.

Custom Film Products.  We develop and produce for customers unique products composed of flexible film, including products for medical applications.

 
5

 

Markets

Foil Balloons

The foil balloon came into existence in the late 1970s. During the 1980s, the market for foil balloons grew rapidly. Initially, the product was sold principally to individual vendors, small retail outlets and at fairs, amusement parks, shopping centers and other outdoor facilities and functions. Foil balloons remain buoyant when filled with helium for extended periods of time and they permit the printing and display of graphics and messages. As a result, the product has significant appeal as a novelty and message item. Foil balloons became part of the "social expression" industry, carrying graphics designs, characters and messages like greeting cards. In the mid-1980s, we and other participants in the market began licensing character and cartoon images for printing on the balloons and directed marketing of the balloons to retail outlets including grocery, general merchandise, discount and drug store chains, card and gift shops, party goods stores as well as florists and balloon decorators. These outlets now represent the principal means for the sale of foil balloons throughout the United States and in a number of other countries, although “vendors” remain a significant means of distribution in a number of areas.

Foil balloons are now sold in virtually every region of the world. The United States, however, remains the largest market for these products.

Foil balloons are sold in the United States and foreign countries directly by producers to retail outlets and through distributors and wholesalers. Often the sale of foil balloons by the wholesalers/distributors is accompanied by related products including latex balloons, floral supplies, candy containers, mugs, plush toys, baskets and a variety of party goods.

Latex Balloons

For a number of years, latex balloons and related novelty/toy latex items have been marketed and sold throughout the United States and in most other countries.  Latex balloons are sold as novelty/toy items, for decorative purposes, as part of floral designs and as party goods and favors.  In addition to standard size and shape balloons, inflatable latex items include punch balls, water bombs, balloons to be twisted into shapes, and other specialty designs.  Often, latex balloons included printed messages or designs.

Latex balloons are sold principally in retail outlets, including party goods stores, general merchandise stores, discount chains, gift stores and drugstore chains.  Balloons are also purchased by balloon decorators and floral outlets for use in decorative or floral designs.

Printed latex balloons are sold both in retail outlets and for balloon decoration purposes including floral designs. "Toy" balloons include novelty balloons sold in toy departments or stores, punch balls, water bombs and other specialty designs.

Latex balloons are sold both through distributors and directly to retail outlets by the producers.

Printed and Specialty Films

The industry and market for printed and specialty films is fragmented and includes many participants. There are hundreds of manufacturers of printed and specialty film products in the United States and in other markets. In many cases, companies who provide food and other products in film packages also produce or process the films used for their packages.  The market for the Company's film products consists principally of companies who utilize the films for the packaging of their products, including food products and other items, usually by converting the film to a flexible container. In addition to the packaging of food products, flexible containers are used for medical purposes (such as colostomy bags, containers for saline solution and other items), "dunnage" (to cushion products being packaged), storage of personal and household items and other purposes.

 
6

 

Flexible Containers/Pouches

The market for flexible containers and pouches is large and diverse.  Many companies engaged in the production of food items package their products in flexible containers or pouches, and, therefore, represent a market for these containers.  Many of these companies purchase film – often printed film – and convert the film to pouches or packages at their own facilities while others purchase completed containers from suppliers.

Flexible containers and pouches are sold and utilized in the consumer market in numerous forms. They include simple open-top plastic bags, resealable bags and zippered bags.  The market also includes containers and pouches of special design or purpose, including vacuumable bags for storage of food or household items, medical bags, or commercial uses.

Marketing, Sales and Distribution

Balloon Products

We market and sell our foil balloon, latex balloon and related novelty products throughout the United States and in a number of other countries.  We maintain a marketing staff, sales staff and support staff of 6 individuals and a customer service department of 3 individuals in the United States. European sales are conducted by CTI Balloons, the Company's subsidiary located in Rugby, England.  In January 2010, we also commenced the sales of balloon products through a facility in Frankfurt, Germany.  Flexo Universal conducts sales and marketing activities for the sale of balloon products in Mexico, Latin America, and certain other markets. Sales in other foreign countries are made generally to distributors in those countries and are managed at the Company's principal offices.

We sell and distribute our balloon products (i) by our employed staffs of sales and customer service personnel in the United States, Mexico and the UK, (ii) through a network of distributors and wholesalers in the United States, Mexico and the UK, (iii) through several groups of independent sales representatives and (iv) to selected retail chains. The distributors and wholesalers are generally engaged principally in the sale of balloons and related products (including such items as plush toys, mugs, containers, floral supplies and other items) and sell balloons and related products to retail outlets including grocery, general merchandise and drug store chains, card and gift shops, party goods stores as well as florists and balloon decorators.

 
7

 

Our largest customer for balloons during 2009 was Dollar Tree Stores.  Sales to this chain in 2009 represented $11,437,000 or approximately 27.7% of our consolidated net sales.

We engage in a variety of advertising and promotional activities to promote the sale of our balloon products. Each year, we produce a complete catalog of our balloon products, and also prepare various flyers and brochures for special or seasonal products, which we disseminate to thousands of customers, potential customers and others.  We participate in several trade shows for the gift, novelty, balloon and other industries and advertise in several trade and other publications.

Printed and Specialty Films

We market and sell printed and laminated films directly and through independent sales representatives throughout the United States.  We sell laminated and printed films to companies that utilize these films to produce packaging for a variety of products, including food products, in both liquid and solid form, such as cola syrup, coffee, juices and other items.  We seek to identify and maintain customer relationships in which we provide value-added in the form of technology or systems.  Our largest customer for film products is Rapak, L.L.C. (“Rapak”) to whom we provide a patented embossed film, as well as other film products.  During 2009, our sales to Rapak totaled $6,360,000, representing 15.4% of our consolidated net sales.  Under our agreement with Rapak, which continues through October 31, 2011, Rapak is committed to purchase at least 75% of its requirements for embossed film from us.

Flexible Containers/Pouches.

We market flexible containers and pouches to various companies for commercial packaging purposes and we market lines of consumer storage packages both to a principal customer and to retail chains and outlets.

On February 1, 2008, we entered into a License and Supply Agreement with S.C. Johnson & Son, Inc (“SC Johnson”).  The agreement provides for the Company to manufacture and sell to SC Johnson (or its designee, Goodwill Commercial Services, Inc.) certain home food management products to be sold under the SC Johnson ZipLoc® brand.  The agreement is for a term expiring on June 30, 2011 and provides for two renewal terms of two years each at the option of SC Johnson.  During 2009, our sales to SC Johnson totaled $4,583,000, representing 11.1% of our consolidated net sales.

We produce consumer storage bags for ITW Space Bag, a division of Illinois Tool Works, Inc. (“ITW”).  In March 2006, we entered into a four-year agreement with ITW, expiring on March 31, 2010, providing for us to supply certain of the pouches which they market under the name Space Bag®.

 
8

 

During 2005, we introduced a line of universal vacuumable bags for household storage of food products. These bags are designed to be used with existing vacuum and sealing devices.  We market these bags through various retail channels.  During 2007, we introduced a line of re-sealable pouches incorporating a valve permitting the evacuation of air from the sealed pouch by use of a hand pump supplied with the pouches.  This line of products is marketed under the brand name ZipVac™.  We market this line of products to various retail outlets.

Production and Operations

We conduct our operations at our facilities:  (i) our headquarters, offices and plant in Barrington, Illinois, consisting of a total of approximately 75,000 square feet of office, production and warehouse space, (ii) a warehouse in Elgin, Illinois consisting of approximately 30,000 square feet, (iii) a plant, office and warehouse in Guadalajara, Mexico, consisting of approximately 43,000 square feet of office, warehouse and production space and (iv) an office and warehouse facility in Rugby, England, consisting of approximately 16,000 square feet of space.

We conduct production operations at our plants in Barrington, Illinois and Guadalajara, Mexico.  At our plants, our production operations include (i) lamination and extrusion coating of films, (ii) slitting of film rolls, (iii) printing on film and on latex balloons, (iv) converting of film to completed products including balloons, flexible containers and pouches and (v) production of latex balloon products.  We perform all of the lamination, extrusion coating and slitting activities in our Barrington, Illinois plant and produce all of our latex balloon products at our Guadalajara, Mexico plant.  We print films in Barrington, Illinois and we print latex balloons in Guadalajara, Mexico.

We warehouse raw materials at our plants in Barrington, Illinois and Guadalajara, Mexico and we warehouse finished goods at our facilities in Barrington, Illinois, Elgin, Illinois, Guadalajara, Mexico and Rugby, England.  We maintain customer service and fulfillment operations at each of our warehouse locations.  We conduct sales operations for the United States and for all other markets, except those handled by our Mexico and England facilities, at the Barrington, Illinois facility.  Sales for Mexico and Latin America are handled at our Guadalajara, Mexico facility and sales for the United Kingdom are handled at our Rugby, England facility.  In January 2010, we commenced the sale of balloon products from a facility in Frankfurt, Germany.

We maintain a graphic arts and development department at our Barrington, Illinois facility which designs our balloon products and graphics. Our creative department operates a networked, computerized graphic arts system for the production of these designs and of printed materials including catalogues, advertisements and other promotional materials.

We conduct administrative and accounting functions at our headquarters in Barrington, Illinois and at our facilities in Guadalajara, Mexico and Rugby, England.

 
9

 

Raw Materials

The principal raw materials we use in manufacturing our products are (i) petroleum or natural gas-based films, (ii) petroleum or natural gas-based resin, (iii) latex and (iv) printing inks.  The cost of raw materials represents a significant portion of the total cost of our products, with the result that fluctuations in the cost of raw materials has a material effect on our profitability. The cost of our raw materials represented 43.9% of our net revenues in 2009 compared to 43.2% in 2008.  During the past several years, we have experienced significant fluctuations in the cost of these raw materials.  We do not have any long-term agreements for the supply of raw materials and may experience wide fluctuations in the cost of raw materials in the future.  Further, although we have been able to obtain adequate supplies of raw materials in the past, there can be no assurance that we will be able to obtain adequate supplies of one or more of our raw materials in the future.

Information Technology Systems

Our corporate headquarters in Barrington, Illinois and our warehouse facility in Elgin, Illinois are serviced by a PC-based local area network.  We connect the facilities via a high speed T1 line that carries both voice and data communications.  Access to the network is available to all appropriate employees but is secured through four Microsoft servers running Active Directory authentication.  The network allows us to leverage printing resources, create shared file areas for cross-departmental functions and allows for a single source backup of critical business files.  On the network we run Macola financial system software.  Macola is a modular software system.  We presently use the general ledger, order entry, inventory management, purchase order, manufacturing costing, controls and inventory controls, electronic data exchange and custom report writing modules of that system.  Internal and external employee communications are handled by industry standard Microsoft Exchange email, allowing us to communicate with customers and vendors all over the world.  We also provide a secure, firewall protected, load balanced and redundant T1 and cable internet connection allowing employees to use e-mail, research issues, support customers and securely move data.

At each of our Mexico and England facilities, we operate server computers and local area networks, accessible to employees at those facilities.  At each of those facilities, we operate separate integrated financial, order entry and inventory management systems.

Competition

The balloon and novelty industry is highly competitive, with numerous competitors. We believe there are presently six principal manufacturers of foil balloons whose products are sold in the United States including Anagram International, Inc., Pioneer Balloon Company, Convertidora International S.A. de C.V., Barton Enterprises Inc., and Betallic, LLC.  Several companies market and sell foil balloons designed by them and manufactured by others for them.

 
10

 

We believe there are approximately five manufacturers of latex balloons whose products are sold in the United States and numerous others whose products are sold in other countries.

We also compete with other manufacturers of foil and latex balloons in Europe, Latin America and Asia.

The market for films, packaging, flexible containers and custom products is fragmented, and competition in this area is difficult to gauge. However, there are numerous participants in this market and the Company can expect to experience intense quality and price competition.

Many of these companies offer products and services that are the same or similar to those offered by us and our ability to compete depends on many factors within and outside our control. There are a number of well-established competitors in each of our product lines, several of which possess substantially greater financial, marketing and technical resources and have established, extensive, direct and indirect channels of distribution for their products and services. As a result, such competitors may be able to respond more quickly to new developments and changes in customer requirements, or devote greater resources to the development, promotion and sale of their products and services than we can. Competitive pressures include, among other things, price competition, new designs and product development and copyright licensing.

Patents, Trademarks and Copyrights

We have developed or acquired a number of intellectual property rights which we believe are significant to our business.

Copyright Licenses.  We maintain licenses on certain popular characters and designs for our balloon products. We presently maintain a number of licenses and produce balloon designs utilizing the characters or designs covered by the licenses. Licenses are generally maintained for a one or two-year term, although the Company has maintained long term relationships with several of its licensors.

Trademarks. We own 9 registered trademarks in the United States relating to our balloon products. Many of these trademarks are registered in foreign countries, principally in the European Union.

Patent Rights.  We own, or have license rights under, or have applied for, patents related to our balloon products, certain film products and certain flexible container products. These include (i) ownership of two patents, relating to self-sealing valves for foil balloons and methods of making balloons with such valves, (ii) several foil balloon design patents, (iii) patents and applications related to the design and structure of, and method of, inserting and affixing, zipper-closure systems in a bag, (iv) patents related to one-way valves for pouches, (v) a patent related to methods of embossing film and utilizing such film to produce pouches with fitments, and (vi) patent applications related to vacuumable storage bags with fitments.

 
11

 

Research and Development

We maintain a product development and research department of five individuals for the development or identification of new products, product components and sources of supply. Research and development includes (i) creative product development, (ii) creative marketing, and (iii) engineering development. During each of the fiscal years ended December 31, 2009 and 2008, we estimate that the total amount spent on research and development activities was approximately $360,000 and $357,000, respectively.

Employees

As of December 31, 2009, the Company had 117 full-time employees in the United States, of whom 23 are executive or supervisory, 6 are in sales, 67 are in manufacturing or warehouse functions and 21 are clerical.  As of that same date, we had 9 full-time employees in England, of whom 3 are executive or supervisory, 2 are in sales, 3 are in warehousing and 1 is clerical.  At Flexo Universal, our Mexico subsidiary, as of December 31, 2009, we had 225 full-time employees, of whom 5 are executive or supervisory, 3 are in sales, 205 are in manufacturing and 12 are clerical.  The Company is not a party to any collective bargaining agreement in the United States, has not experienced any work stoppages and believes that its relationship with its employees is satisfactory.

Regulatory Matters

Our manufacturing operations in the United States are subject to the U.S. Occupational Safety and Health Act ("OSHA").  We believe we are in material compliance with OSHA. The Company generates liquid, gaseous and solid waste materials in its operations in Barrington, Illinois and the generation, emission or disposal of such waste materials are, or may be, subject to various federal, state and local laws and regulations regarding the generation, emission or disposal of waste materials.  We believe we are in material compliance with applicable environmental rules and regulations. Several states have enacted laws limiting or restricting the release of helium filled foil balloons. We do not believe such legislation will have any material effect on our operations.

International Operations

We sell balloon products in a number of countries outside of the United States.  Our facility and personnel in Rugby, England handle the sales of these products in the United Kingdom. Our facility and personnel in Guadalajara, Mexico handle the sales of these products in Mexico and Latin America.  In January 2010, we commenced the sale of novelty products in Europe through a facility in Frankfurt, Germany.  In other countries, we sell balloon products through distributors located in those countries. We conduct production, packaging, warehousing and sales operations in Mexico. We conduct warehousing and sales operations in the United Kingdom. We rely, and are dependent, on our operations in Mexico for the supply of latex balloons in the United States, Mexico, Europe and other markets. Interruption of that supply would have a materially adverse effect on the business of the Company.

 
12

 

Our domestic and international sales to outside customers and assets by area over the period 2008 - 2009 have been as follows:

   
United States
   
United Kingdom
   
Mexico
   
Consolidated
 
Year ended 12/31/09
                       
Sales to outside customers
  $ 31,873,000     $ 1,971,000     $ 7,451,000     $ 41,295,000  
Total Assets
  $ 23,801,000     $ 733,000     $ 5,861,000     $ 30,395,000  
                                 
   
United States
   
United Kingdom
   
Mexico
   
Consolidated
 
Year ended 12/31/08
                               
Sales to outside customers
  $ 34,701,000     $ 2,762,000     $ 7,518,000     $ 44,981,000  
Total Assets
  $ 24,709,000     $ 740,000     $ 4,539,000     $ 29,988,000  

Item No. 1B – Unresolved Staff Comments
 
As of the filing of this Annual report on Form 10-K, we had no unresolved comments from the staff of the Securities and Exchange Commission that were received not less than 180 days before the end of our 2009 fiscal year.
 
Item No. 2 - Properties

We own our principal plant and offices located in Barrington, Illinois, approximately 45 miles northwest of Chicago, Illinois. The facility includes approximately 75,000 square feet of office, manufacturing and warehouse space. This facility is subject to a mortgage loan in the principal amount of $2,800,000, having a term of 5 years, with payments amortized over 25 years.

We have entered into a month-to-month agreement to rent approximately 30,000 square feet of warehouse space as required in Elgin, Illinois.

During a portion of 2009, we leased approximately 16,000 square feet of warehouse space in Cary, Illinois.  The lease for this space expired in September 2009.

CTI Balloons, Ltd. leases approximately 15,000 square feet of office and warehouse space in Rugby, England at an annual lease cost of $46,980, expiring in 2019. This facility is utilized to warehouse balloon products and to manage and service the Company's operations in England.

 
13

 

In February 2008, Flexo Universal entered into a 3-year lease agreement for the lease of approximately 43,000 square feet of manufacturing, warehouse and office space in Guadalajara, Mexico at the cost of $19,200 per month.

We believe that our properties have been adequately maintained, are in generally good condition and are suitable for our business as presently conducted. We believe our existing facilities provide sufficient production capacity for our present needs and for our presently anticipated needs in the foreseeable future. We also believe that, with respect to leased properties, upon the expiration of our current leases, we will be able to either secure renewal terms or to enter into leases for alternative locations at market terms.

Item No. 3 Legal Proceedings

On December 20, 2006, Pliant Corporation filed an action against the Company in the Circuit Court of Cook County, Illinois.  In the action, Pliant claimed that there was due from the Company to Pliant the sum of $245,000 for goods sold and delivered by Pliant to the Company as well as interest on such amount.  On September 30, 2009, this action was settled and dismissed in consideration of a payment to Pliant Corporation by the Company in the amount of $125,000.

In addition, the Company is also party to certain lawsuits or claims arising in the normal course of business. The ultimate outcome of these matters is unknown, but in the opinion of management, we do not believe any of these proceedings will have, individually or in the aggregate, a material adverse effect upon our financial condition, cash flows or future results of operation.
 
PART II

Item No. 5 Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information. The Company's Common Stock was admitted to trading on the NASDAQ SmallCap Market (now the NASDAQ Capital Market) under the symbol CTIB on November 5, 1997.

The high and low sales prices for the last eight fiscal quarters (retroactively adjusted to reflect post-reverse split share and stock dividend values), according to the NASDAQ Stock Market's Stock Price History Report, were:

 
14

 

   
High
   
Low
 
January 1, 2008 to March 31, 2008
 
$6.43
    $3.25  
April 1, 2008 to June 30, 2008
    6.10       4.16  
July 1, 2008 to September 30, 2008
    7.30       4.50  
October 1, 2008 to December 31, 2008
    5.29       1.60  
January 1, 2009 to March 31, 2009
    2.65       1.20  
April 1, 2009 to June 30, 2009
    2.50       1.23  
July 1, 2009 to September 30, 2009
    2.65       1.75  
October 1, 2009 to December 31, 2009
    2.84       1.95  

As of December 31, 2009 there were approximately 31 holders of record of the Company’s Common Stock.  The Company believes that its total number of beneficial owners of common stock of the Company exceeds 600.

The Company has never paid any cash dividends on its Common Stock.  The Company currently intends to retain all its earnings to finance the development and expansion of its business. Under the terms of its current loan agreement, the Company is restricted from declaring any cash dividends or other distributions on its shares.

Item No. 7 Management's Discussion and Analysis of Financial Condition and Results of Operations

Overview

The Company produces film products for novelty, packaging and container and custom product applications. These products include foil balloons, latex balloons and related latex toy products, films for packaging applications, flexible containers for packaging and storage applications and custom film products. We produce all of our film products for packaging and container applications at the facilities in Barrington, Illinois. We produce all of our latex balloons and latex products at our facility in Guadalajara, Mexico. Substantially all of our film products for packaging applications and flexible containers for packaging and storage are sold to customers in the United States. We market and sell our novelty items - principally foil balloons and latex balloons - in the United States, Mexico, the United Kingdom and a number of additional countries.

Our revenues from each of our product categories in each of the past two years have been as follows:
 
   
(000 Omitted)
   
$
 
% of
 
$
 
% of
Product Category
 
2009
 
Net Sales
 
2008
 
Net Sales
                 
Metalized Balloons
 
19,824
 
48.0%
 
17,629
 
 
39.2%
                 
Film Products
 
6,913
 
 
16.7%
 
8,212
 
 
18.3%
                 
Pouches
 
6,895
 
 
16.7%
 
10,893
 
 
24.2%
           
 
   
Latex Balloons
 
7,024
 
 
17.0%
 
7,597
 
 
16.9%
           
 
   
Helium/Other
 
639
 
 
1.6%
 
650
 
 
1.4%
                 
Total
 
41,295
 
 
100.0%
 
44,981
 
 
100.0%


 
15

 

Our primary expenses include the cost of products sold and selling, general and administrative expenses.

Cost of products sold primarily consists of expenses related to raw materials, labor, quality control and overhead expenses such as supervisory labor, depreciation, utilities expense and facilities expense directly associated with production of our products, as well as shipping costs relating to the shipment of products to customers.  Cost of products sold is impacted by the cost of the raw materials used in our products, the cost of shipping, along with our efficiency in managing the production of our products.

Selling, general and administrative expenses include the compensation and benefits paid to our employees, all other selling expenses, marketing, promotional expenses, travel and other corporate administrative expenses. These other corporate administrative expenses include professional fees, depreciation of equipment and facilities utilized in administration, occupancy costs, communication costs and other similar operating expenses. Selling, general and administrative expenses can be affected by a number of factors, including staffing levels and the cost of providing competitive salaries and benefits, the cost of regulatory compliance and other administrative costs.

Purchases by a limited number of customers represent a significant portion of our total revenues. In 2009, sales to our top 10 customers represented 70.2% of net revenues.  During 2009, there were three customers to whom our sales represented more than 10% of net revenues.  Our principal customers and 2009 sales to them were:

Customer
 
Product
 
2009 Sales
   
% of 2009
Revenues
   
2008 Sales
   
% of 2008
Revenues
 
                             
Dollar Tree Stores
 
Balloons
  $ 11,437,000      
27.7%
    $ 9,014,000      
20.0%
 
Rapak L.L.C
 
Films
  $ 6,360,000      
15.4%
    $ 7,608,000      
16.9%
 
S.C. Johnson & Son, Inc
 
Pouches
  $ 4,583,000      
11.1%
    $ 6,990,000      
15.5%
 

The loss of one or more of these principal customers, or a significant reduction in purchases by one or more of them, could have a material adverse effect on our business.

Except as previously described (see page 8), we generally do not have agreements with our customers under which customers are obligated to purchase any specific or minimum amount of product from us.

Results of Operations

The following table sets forth selected results of our operations expressed as a percentage of net sales for the years ended December 31, 2009 and 2008. Our results of operations for the periods described below are not necessarily indicative of results of operations for future periods.

 
16

 

   
Year ended December 31,
 
   
2009
   
2008
 
             
Net sales
   
100.0%
      100.0%  
Costs and expenses:
               
Cost of products sold
    77.7       77.1  
Operating Expenses
    16.9       17.6  
                 
Income from operations
    5.4       5.3  
Interest expense
    (2.7)       (2.3)  
Other income
    0.0       0.1  
                 
Income before income taxes
    2.7       3.1  
Provision for income taxes
    0.3       0.5  
                 
Net profit
    2.4%       2.6%  

Year Ended December 31, 2009 Compared to Year Ended December 31, 2008

Net Sales

For the fiscal year ended December 31, 2009, consolidated net sales from the sale of all products were $41,295,000 compared to consolidated net sales of $44,981,000 for the year ended December 31, 2008, a decrease of 8%.

Sales of foil balloons increased by 12.5% from $17,629,000 in 2008 to $19,824,000 in 2009.  Most of the increase is attributable to an increase in 2009 in our sales to Dollar Tree Stores of $2,423,000 over 2008 sales.

Sales of film products decreased by 15.8% from $8,212,000 in 2008 to $6,913,000 in 2009.  This decrease is attributable to a decrease in sales to Rapak, L.L.C.

Sales of pouch products decreased by 36.7% from $10,893,000 in 2008 to $6,895,000 in 2009.  This decrease is attributable to a decrease in pouch sales to Goodwill Commercial Services (for S.C. Johnson & Son, Inc.) from $6,990,000 in 2008 to $4,583,000 in 2009 and to ITW Spacebag from $2,956,000 in 2008 to $1,258,000 in 2009.  We anticipate that sales of pouches to ITW Spacebag will continue to decline in 2010.  Other pouch sales in 2009 included sales of our ZipVac Brand line.

Sales of latex balloons decreased by 7.5% from $7,597,000 in 2008 to $7,024,000 in 2009.  The decline in the dollar volume of latex balloon sales in 2009 compared to 2008 is attributable to the fact that a relatively high percentage of our latex balloons sales are of balloons produced and sold in Mexico and, although the unit volume of latex balloon sales in Mexico during 2009 was greater than in 2008, the dollar volume in 2009 is lower due to the decline in the value of the Mexican peso in that period.

 
17

 

Cost of Sales

Cost of sales increased from 77.1% of sales in 2008 to 77.7% of sales in 2009.   The increase in cost of goods as a percentage of sales during 2009 is the result of a change in the mix of products sold, reflecting increased sales of certain novelty balloon products having a higher level of cost as a percentage of sales than other products.

General and Administrative Expenses

General and administrative expenses decreased from $5,376,000 in 2008 or 12.0% of net sales to $4,539,000 or 11.0% of net sales in 2009.  This decrease is attributable principally to (i) a decrease in administrative salaries of $92,000, (ii) a decrease in administrative travel expenses in the amount of $42,000, (iii) a decrease in audit expenses of $63,000 and (iv) a decrease in legal expenses of $99,000.

Selling

Selling expenses decreased from $886,000 or 2.0% of sales in 2008 to $871,000 or 2.1% of sales in 2009.  This decreased is attributable principally to (i) a decrease in salary expense of $118,000, (ii) a decrease in travel expenses in the amount of $61,000 (iii) a decrease in licensing royalty payments in the amount of $34,000 and (iv) these decreases were offset by an increase in consulting selling expense of $211,000.

Advertising and Marketing

Advertising and marketing expenses decreased from $1,678,000 or 3.7% of sales in 2008 to $1,576,000 or 3.8% of sales in 2009.  This decrease is attributable principally to (i) a decrease in marketing and promotion expenses of $92,000, (ii) a decrease in artwork and films in the amount of $93,000 and (iii) and decrease in trade booth expense of $56,000.

Other Income or Expense

During 2009, we incurred net interest expense of $1,085,000 compared to net interest expense of $1,031,000 during 2008.

During 2009, we realized a foreign currency loss in the amount of $20,000 compared to foreign currency gain in 2008 of $50,000.

 
18

 

Net Income or Loss

During 2009, we had net income of $1,003,000 compared to net income of $1,154,000 in 2008.  The decline in net income for 2009 compared to 2008 is the result principally of a modest decline in both sales and gross margins.

Income Taxes

In 2009, the Company recognized income tax expense, on a consolidated basis, of $114,000.  This income tax expense is composed of an income tax benefit realized by CTI Balloons, our United Kingdom subsidiary, in the amount of $96,000 and an income tax expense by Flexo Universal, our Mexico subsidiary, in the amount of $210,000.  In 2008, the Company recognized income tax expense, on a consolidated basis, of $247,000.  This income tax expense is composed of income tax expense realized by CTI Balloons, our United Kingdom subsidiary, in the amount of $116,000 and by Flexo Universal and CTI Mexico, our Mexico subsidiaries, in the amounts of $119,000 and $12,000, respectively.  The Company did not recognize any income tax expense in the United States in 2009 or 2008 by reason of its net operating loss carryforward and adjustments to the Company’s reserve in its deferred tax asset account.

Financial Condition, Liquidity and Capital Resources

Cash Flow Provided by Operating Activities    During fiscal 2009, cash provided by operating activities amounted to $3,113,000, compared to cash flow provided by operating activities during fiscal 2008 of $401,000.  Significant changes in working capital items affecting cash flow provided by operating activities were:

 
·
Depreciation and amortization of $1,958,000
 
·
A decrease in net inventory of $948,000
 
·
An increase in accounts receivable of $1,411,000
 
·
An increase in prepaid expenses and other assets of $283,000
 
·
An increase in accrued liabilities of $588,000

The decrease in inventory during 2009 is the result of our efforts to control the inventory levels of finished goods.  We do not anticipate significant changes in inventory levels during 2010.  The increase in accounts receivable reflects a temporary increase due to high levels of sales in December 2009.  Accordingly, we expect the receivables level to decline during the first half of 2010.

Cash Used in Investing Activities   During fiscal 2009, cash used in investing activities amounted to $732,000 compared to cash used in investing activities during fiscal 2008 of $2,200,000.  Cash used in investing activities was principally for the purchase of production equipment.  Although we do not presently have any commitments for capital expenditures, we do anticipate that the level of capital expenditures in 2010 will increase over 2009 and will include maintenance capital expenditure levels of approximately $500,000 as well as certain other capital expenditures for new equipment or improvements.

 
19

 

Cash Provided by Financing Activities   During fiscal 2009, cash used in financing activities amounted to $1,728,000, compared to cash provided by financing activities of $1,681,000 during fiscal 2008.  During 2009, we repaid long-term debt of $1,251,000 and reduced by $362,000 the amount outstanding under our revolving line of credit.

On February 1, 2006, we entered into a Loan Agreement with RBS, Chicago, Illinois, under which, as amended, the Bank has agreed to provide a credit facility to our Company in the total amount of $15,300,000, which includes (i) a five year mortgage loan secured by our Barrington, Illinois property in the principal amount of $2,800,000, amortized over a 25 year period, (ii) a five year term-loan secured by our equipment at the Barrington, Illinois plant in the amount of $3,500,000 and (iii) a three-year revolving line of credit up to a maximum amount of $9,000,000, secured by inventory and receivables.  On January 26, 2010, we entered into an amendment of the loan agreement extending the term of the revolving line of credit to April 30, 2010 and amending certain covenants.  The amount we can borrow on the revolving line of credit includes 85% of eligible accounts receivable and 60% of eligible inventory.

Certain terms of the loan agreement include:

 
·
Restrictive Covenants:  The Loan Agreement includes several restrictive covenants under which we are prohibited from, or restricted in our ability to:
 
o
Borrow money;
 
o
Pay dividends and make distributions;
 
o
Issue stock;
 
o
Make certain investments;
 
o
Use assets as security in other transactions;
 
o
Create liens;
 
o
Enter into affiliate transactions;
 
o
Merge or consolidate; or
 
o
Transfer and sell assets.

 
·
Financial Covenants:  The loan agreement includes a series of financial covenants we are required to meet including:
 
o
We are required to maintain a tangible net worth in excess of $3,500,000;
 
o
We are required to maintain specified ratios of senior debt to EBITDA on an annual basis and determined quarterly commencing as of June 30, 2006; and,
 
o
We are required to maintain a specified level of EBITDA to fixed charges for the six months ending June 30, 2006, the nine months ending September 30, 2006 and twelve months thereafter.

As of December 31, 2009 the Company was in compliance with these financial covenants.

 
20

 

The loan agreement as amended provides for interest at varying rates in excess of the Bank’s prime rate, depending on the level of senior debt to EBITDA over time.  The initial interest rate under the loan is prime plus 1.5% per annum.  On a quarterly basis, this ratio will be measured and the interest rate changed in accordance to the table below.

When Senior Debt to EBITDA is: 
 
The Premium
to the Prime
Rate is:
 
Greater or equal to 4.00 to 1.00
    1.50 %
Greater than or equal to 3.50 to 1.00; Less than 4.00 to 1.00
    1.25 %
Greater than or equal to 3.25 to 1.00; Less than 3.50 to 1.00
    1.00 %
Greater than or equal to 2.75 to 1.00; Less than 3.25 to 1.00
    0.75 %
 Less than 2.75 to 1.00
    0.50 %

At December 31, 2009 the Company was paying a premium of 0.75% over Prime.

Also, under the loan agreement, we were required to purchase a swap agreement with respect to part of the mortgage and term loan portions of our loan. On April 5, 2006, we entered into a swap arrangement with RBS with respect to 60% of the principal amounts of the mortgage loan and the term loan, which had the effect of fixing the interest rate for such portions of the loans at 8.49% for the balance of the loan terms.  On January 28, 2008, we entered into another swap agreement with respect to $3,000,000 in principal amount of our revolving loan fixing the interest rate for this portion of the revolving loan at 6.17%.  The value of these swap agreements vary as the result of variations in interest rates.  We record changes in the valuation of these swap agreements as other comprehensive income (or expense).  As of December 31, 2009, the net effect of the changes in the value of these swap agreements is a liability of $189,000.

Each of John H. Schwan and Stephen M. Merrick, officers, directors and principal shareholders of the Company have personally guaranteed the obligations of the company to RBS up to $2,000,000.

On November 13, 2007, RBS granted to the Company a capital lease line of credit of up to $1,500,000 to fund equipment acquisitions by the Company.  During the years ended December 31, 2009 and 2008, the Company received aggregate advances under this line of $0 and $1,224,000, respectively.

On February 1, 2006, two principal officers and shareholders of our Company each loaned to our Company the sum of $500,000 in exchange for (i) Promissory Notes due January 31, 2011 and bearing interest at the rate of 2% per annum in excess of the prime rate determined quarterly and (ii) five year Warrants to purchase up to 151,515 shares of common stock of the Company at the price of $3.30 per share (110% of the closing market price on the day preceding the date of the loans).

 
21

 

Current Assets.  As of December 31, 2009, the total current assets of the Company were $19,148,000, compared to total current assets of $17,688,000 at December 31, 2008.  The change in current assets reflects, principally, (i) a decrease in inventories of $861,000, and (ii) an increase in cash and equivalents of $690,000, (iii) an increase in the net deferred income tax asset of $32,000, and (iv) an increase in prepaid expenses and other current assets of $101,000.

Property, Plant and Equipment.  During fiscal 2009, the Company invested $732,000 in capital items, principally in production equipment and plant improvements.

Current Liabilities.  Accrued other liabilities includes $776,000 in payroll accruals and $189,000 in mark to market liabilities.  Total current liabilities increased from $16,222,000 as of December 31, 2008 to $16,735,000 as of December 31, 2009.  Changes in current liabilities included: (i) an increase of $84,000 in trade payables, (ii) a decrease of the line of credit of $362,000, (iii) an increase in the balance of the current portion of long term indebtedness of $20,000 and (iv) an increase in the balance of notes payable to officers of $6,000.

Liquidity and Capital Resources; Working Capital.  As of December 31, 2009, our current assets exceeded our current liabilities by $2,414,000, we had cash and cash equivalents of $870,000 and there was available under our line of credit up to $868,000 in additional funds.  Management believes that these available funds, our internally generated funds and the borrowing capacity under our revolving line of credit facility will be sufficient to meet working capital requirements for the remainder of 2010.  The Company is in negations for, and believes it will be able to conclude, an agreement for the extension of its current line of credit or other loan agreement.

Shareholders’ Equity.  Shareholders’ equity was $8,763,000 as of December 31, 2009 compared to $7,735,000 as of December 31, 2008.

Seasonality

In the foil product line, sales have historically been seasonal with approximately 45% occurring in the period from December through March of the succeeding year and 21% being generated in the period July through October in recent years. The sale of latex balloons, pouches and laminated film products have not historically been seasonal, and as sales in these products lines have increased as a percentage of total sales, the seasonality of the Company's total net sales has decreased.

Critical Accounting Policies

The financial statements of the Company are based on the selection and application of significant accounting policies which require management to make various estimates and assumptions. The following are some of the more critical judgment areas in the application of our accounting policies that currently affect our financial condition and results of operation.

 
22

 

Revenue Recognition. Substantially all of the Company's revenues are derived from the sale of products. With respect to the sale of products, revenue from a transaction is recognized when (i) a definitive arrangement exists for the sale of the product, (ii) delivery of the product has occurred, (iii) the price to the buyer has been fixed or is determinable and (iv) collectibility is reasonably assured. The Company generally recognizes revenue for the sale of products when the products have been shipped and invoiced. In some cases, product is provided on consignment to customers. In those cases, revenue is recognized when the customer reports a sale of the product.

Allowance for Doubtful Accounts. We estimate our allowance for doubtful accounts based on an analysis of specific accounts, an analysis of historical trends, payment and write-off histories. Our credit risks are continually reviewed and management believes that adequate provisions have been made for doubtful accounts. However, unexpected changes in the financial condition of customers or changes in the state of the economy could result in write-offs, which exceed estimates and negatively impact our financial results.

Inventory Valuation. Inventories are stated at the lower of cost or market. Cost is determined using standard costs which approximate costing determined on a first-in, first out basis. Standard costs are reviewed and adjusted at the time of introduction of a new product or design, periodically and at year-end based on actual direct and indirect production costs.  On a periodic basis, the Company reviews its inventory levels for estimated obsolescence or unmarketable items, in reference to future demand requirements and shelf life of the products. As of December 31, 2009, the Company had established a reserve for obsolescence, marketability or excess quantities with respect to inventory in the aggregate amount of $342,000.  As of December 31, 2008, the amount of the reserve was $429,000. In addition, on a periodic basis, the Company disposes of inventory deemed to be obsolete or unsaleable and, at such time, records an expense for the value of such inventory.  We record freight income as a component of net sales and record freight costs as a component of cost of goods sold.

Valuation of Long-Lived Assets. We evaluate whether events or circumstances have occurred which indicate that the carrying amounts of long-lived assets (principally property and equipment and goodwill) may be impaired or not recoverable. Significant factors which may trigger an impairment review include: changes in business strategy, market conditions, the manner of use of an asset, underperformance relative to historical or expected future operating results, and negative industry or economic trends. We apply the provisions of FASB GAAP USA under which goodwill is evaluated at least annually for impairment.  We conducted a valuation analysis of our goodwill in our Mexico subsidiary for the year ended December 31, 2009 and 2008.  And determined that the recorded value of the Company’s interest in Flexo Universal as recorded for December 31, 2006 was not impaired.

Foreign Currency Translation.  All balance sheet accounts are translated using the exchange rates in effect at the balance sheet date.  Statements of operations amounts are translated using the average exchange rates for the year-to-date periods.  The gains and losses resulting from the changes in exchange rates during the period have been reported in other comprehensive income or loss.

 
23

 

Stock-Based Compensation.  We have adopted FASB GAAP USA which requires all stock-based payments to employees, including grants of employee stock options, to be recognized in the consolidated financial statements based on their grant-date fair values.

We use the Black-Scholes option pricing model to determine the fair value of stock options which requires us to estimate certain key assumptions.  In accordance with the application of FASB GAAP USA, we incurred employee stock-based compensation cost of $87,000 for the year ended December 31, 2009.  At December 31, 2009, we had $97,000 of unrecognized compensation cost relating to stock options.

Income Taxes and Deferred Tax Assets.  Income taxes are accounted for as prescribed in FASB GAAP USA.  Under the asset and liability method of GAAP USA, the Company recognizes the amount of income taxes currently payable.  Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities, and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years these temporary differences are expected to be recovered or settled.

As of December 31, 2009, the Company had a net deferred tax asset of $1,068,000 (deferred tax assets of $1,597,000 less a valuation allowance of $529,000) representing the amount the Company may recover in future years from future taxable income.  As of December 31, 2008, the amount of the net deferred tax asset was $1,017,000.  Each quarter and year-end management makes a judgment to determine the extent to which the deferred tax asset will be recovered from future taxable income.  Management reduced the valuation allowance related to the deferred tax asset by $373,000 in 2009 from $902,000 as of December 31, 2008 to $529,000 as of December 31, 2009.

Fair Value Measurements

In September 2006, the FASB issued FASB GAAP USA which defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements.  FASB GAAP USA clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants.  FASB GAAP USA also requires that a fair value measurement reflect the assumptions market participants would use in pricing an asset or liability based upon the best information available.  In February 2008, the FASB issued guidance now codified in FASB GAAP USA which provides for delayed application of certain guidance related to non-financial assets and non-financial liabilities, except for items that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually).

 
24

 

In February 2007, the FASB issued FASB GAAP USA which permits companies to choose to measure certain financial instruments and other items at fair value.  The standard requires that unrealized gains and losses are reported in earnings for items measured using the fair value option.  FASB GAAP USA is effective for us on January 1, 2008.  We did not elect the fair value option for any assets or liabilities that were not previously carried at fair value.  Accordingly, the adoption of FASB GAAP USA had no impact on our consolidated financial statements.

In October 2008, the FASB issued clarification to FASB GAAP USA which clarifies the application of FASB GAAP USA in a market that is not active, and addresses application issues such as the use of internal assumptions when relevant observable data does not exist, the use of observable market information when the market is not active, and the use of market quotes when assessing the relevance of observable and unobservable data.  FASB GAAP USA is effective for all periods presented in accordance with FASB GAAP USA.  The adoption of FASB GAAP USA did not have a significant impact on our consolidated financial statements.
 
Reclassifications and Adoption of New Accounting Pronouncements
 
Certain amounts in the 2008 consolidated financial statements have been reclassified to conform to the current period presentation. In addition, as of January 1, 2009 we adopted the following accounting pronouncement that required retrospective application, in which all periods presented reflect the necessary changes.
 
As of January 1, 2009, we adopted a new generally accepted accounting principle related to noncontrolling interests in consolidated financial statements, which changed the reporting for minority interest in our consolidated majority owned subsidiary by re-characterizing as a noncontrolling interest and re-classifying such minority interest as a component of equity in our consolidated balance sheets. This principle also changed the presentation of the income allocated to the minority interest by re-characterizing it as allocation to noncontrolling interest and re-classifying such income as an adjustment to net income to arrive at net income attributable to the Company.
 
As of June 30, 2009, we adopted a new generally accepted accounting principle related to subsequent events which provides guidance on our assessment of subsequent events. The new standard clarifies that we must evaluate, as of each reporting period, events or transactions that occur after the balance sheet date through the date that the financial statements are issued. We performed our assessment of subsequent events and all material events or transactions since December 31, 2009 have been integrated into our disclosures in the accompanying consolidated financial statements.

Item No. 7A - Qualitative And Quantitative Disclosures Regarding Market Risk

Not applicable.

Item No. 8 Financial Statements and Supplementary Data

Reference is made to the Consolidated Financial Statements contained in Part IV hereof.

 
25

 

Item No. 9 Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None

Item No. 9A - Controls and Procedures

Disclosure Controls and Procedures

As required by Rule 13a-15(b) under the Exchange Act, we conducted an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer (together the “Certifying Officers”), of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2009, the end of the period covered by this report.  Based upon that evaluation, the Certifying Officers concluded that our disclosure controls and procedures were effective as of December 31, 2009 to provide reasonable assurance that the information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Certifying Officers, as appropriate, to allow for timely decisions regarding required disclosure.  There were no material changes in our internal control over financial reporting during the fourth quarter of 2009 that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.

Management’s Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. Internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures are being made only in accordance with authorizations of the management and the Board; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of Company assets that could have a material effect on the financial statements.

 
26

 

Our management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control – Integrated Framework issued by the Committee Sponsoring Organizations of the Treadway Commission.  This evaluation included review of the documentation of controls, evaluation of the design effectiveness of controls, testing of the operation effectiveness of controls and a conclusion on this evaluation.  Although there are inherent limitations in the effectiveness of any system of internal controls over financial reporting, based on our evaluation, management has concluded our internal controls over financial reporting were effective as of December 31, 2009.

This annual report does not include an attestation report of the company’s registered public accounting firm regarding internal control over financial reporting.  Management’s report was not subject to attestation by the company’s registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit the company to provide only management’s report in this annual report.

Item 9B – Other Information

None

PART III

Item No. 10 – Directors and Executive Officers of the Registrant

Information called for by Item 9 of Part III is incorporated by reference to the definitive Proxy Statement for the 2010 Annual Meeting of Shareholders which is expected to be filed with the Commission within 120 days after December 31, 2009.

Item No. 11 – Executive Compensation

Information called for by Item 10 of Part III is incorporated by reference to the definitive Proxy Statement for the 2010 Annual Meeting of Shareholders which is expected to be filed with the Commission within 120 days after December 31, 2009.

Item No. 12 – Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Information called for by Item 11 of Part III is incorporated by reference to the definitive Proxy Statement for the 2010 Annual Meeting of Shareholders which is expected to be filed with the Commission within 120 days after December 31, 2009.

Item No. 13 – Certain Relationships and Related Transactions

Information called for by Item 12 of Part III is incorporated by reference to the definitive Proxy Statement for the 2010 Annual Meeting of Shareholders which is expected to be filed with the Commission within 120 days after December 31, 2009.

 
27

 

Item No. 14 – Principal Accountant Fees and Services

Information called for by Item 13 of Part III is incorporated by reference to the definitive Proxy Statement for the 2010 Annual Meeting of Shareholders which is expected to be filed with the Commission within 120 days after December 31, 2009.

PART IV

Item No. 15 Exhibits and Financial Statement Schedules

 
1.
The Consolidated Financial Statements filed as part of this report on Form 10-K are listed on the accompanying Index to Consolidated Financial Statements and Consolidated Financial Statement Schedules.

 
2.
Financial schedules required to be filed by Item 8 of this form, and by Item 15(d) below:

Schedule II       Valuation and qualifying accounts

All other financial schedules are not required under the related instructions or are inapplicable and therefore have been omitted.

 
3.
Exhibits:

Exhibit
   
Number
 
Document
     
3.1
 
Third Restated Certificate of Incorporation of CTI Industries Corporation (Incorporated by reference to Exhibit A contained in Registrant’s Schedule 14A Definitive Proxy Statement for solicitation of written consent of shareholders, as filed with the Commission on October 25, 1999)
3.2
 
By-Laws of CTI Industries Corporation (Incorporated by reference to Exhibits, contained in Registrant’s Form SB-2 Registration Statement (File No. 333-31969) effective November 5, 1997)
4.1
 
Form of CTI Industries Corporation’s common stock certificate (Incorporated by reference to Exhibits, contained in Registrant’s Form SB-2 Registration Statement (File No. 333-31969) effective November 5, 1997)
10.1
 
CTI Industries Corporation 1999 Stock Option Plan (Incorporated by reference to Exhibit contained in Registrant’s Schedule 14A Definitive Proxy Statement, as filed with the Commission on March 26, 1999)
10.2
 
CTI Industries Corporation 2001 Stock Option Plan (Incorporated by reference to Exhibit contained in Registrant’s Schedule 14A Definitive Proxy Statement, as filed with the Commission on May 21, 2001)

 
28

 

10.3
 
CTI Industries Corporation 2002 Stock Option Plan (Incorporated by reference to Exhibit contained in Registrant’s Schedule 14A Definitive Proxy Statement, as filed with the Commission on May 15, 2002)
10.4
 
CTI Industries Corporation 2007 Stock Incentive Plan (Incorporated by reference to Exhibit contained in Registrant’s Schedule 14A Definitive Proxy Statement, as filed with the Commission on April 30, 2007)
10.5
 
Employment Agreement dated June 30, 1997, between CTI Industries Corporation and Howard W. Schwan (Incorporated by reference to Exhibits, contained in Registrant’s Form SB-2 Registration Statement (File No. 333-31969) effective November 5, 1997.)
10.6
 
Warrant dated July 17, 2001 to purchase 79,364 shares of Common Stock John H. Schwan (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)
10.7
 
Warrant dated July 17, 2001 to purchase 39,683 shares of Common Stock Stephen M. Merrick (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)
10.8
 
Note dated January 28, 2003, CTI Industries Corporation to Stephen M. Merrick in the sum of $500,000 (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)
10.9
 
Note dated February 28, 2003, CTI Industries Corporation to Stephen M. Merrick in the sum of $200,000 (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)
10.10
 
Note dated February 10, 2003, CTI Industries Corporation to John H. Schwan in the sum of $150,000 (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)
10.11
 
Note dated February 15, 2003, CTI Industries Corporation to John Schwan in the sum of $680,000 (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)
10.12
 
Note dated March 3, 2003, CTI Industries Corporation to John H. Schwan in the sum of $100,000 (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)
10.13
 
Warrant dated March 20, 2003, to purchase 70,000 shares of Common Stock - Stephen M. Merrick (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)

 
29

 

10.14
 
Warrant dated March 20, 2003, to purchase 93,000 shares of Common Stock - John H. Schwan (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)
10.15
 
Loan and Security Agreement between RBS Citizens, N.A. and the Company dated February 1, 2006 (Incorporated by reference to Exhibits contained in Registrant’s Report on Form 8-K dated February 3, 2006)
10.16
 
Warrant dated February 1, 2006, to purchase 151,515 shares of Common Stock - John H. Schwan (Incorporated by reference to Exhibits contained in Registrant’s Report on Form 8-K dated February 3, 2006)
10.17
 
Warrant dated February 1, 2006, to purchase 151,515 shares of Common Stock – Stephen M. Merrick (Incorporated by reference to Exhibits contained in Registrant’s Report on Form 8-K dated February 3, 2006)
10.18
 
Note dated February 1, 2006, CTI Industries Corporation to John Schwan in the sum of $500,000 (Incorporated by reference to Exhibits contained in Registrant’s Report on Form 8-K dated February 3, 2006)
10.19
 
Note dated February 1, 2006, CTI Industries Corporation to Stephen M. Merrick in the sum of $500,000 (Incorporated by reference to Exhibits contained in Registrant’s Report on Form 8-K dated February 3, 2006)
10.20
 
Production and Supply Agreement between ITW Spacebag and the Company dated March 17, 2006 (Incorporated by reference to Exhibits contained in Registrant’s Report on Form 8-K dated March 17, 2006)
10.21
 
License Agreement between Rapak, LLC and the Company dated April 28, 2006 (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 8-K dated May 3, 2006)
10.22
 
Second Amendment to Loan Agreement between RBS Citizens, N.A. and the Company dated December 18, 2006 (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 8-K dated December 21, 2006.)
10.23
 
Third Amendment to Loan Agreement between RBS Citizens, N.A. and the Company dated November 13, 2007 (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 10-Q dated November 13, 2007)
10.24
 
CTI Industries Corporation Incentive Compensation Plan (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 8-K dated October 2, 2007)
10.25
 
Supply and License Agreement among Registrant and S.C. Johnson & Son, Inc. dated February 1, 2008 (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 8-K/A dated March 19, 2008)

 
30

 

10.26
 
Agreement between Babe Winkelman Productions Inc and the Company dated April 10, 2008 (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 8-K dated April 14, 2008)
10.27
 
Amendment to the License Agreement between Rapak, LLC and the Company dated May 6, 2008 (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 8-K dated May 8, 2008)
10.28
 
Fifth Amendment to Loan Agreement between RBS Citizens, N.A. and the Company dated January 30, 2009 (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 8-K dated February 2, 2009)
10.29
 
Sixth Amendment to Loan Agreement between RBS Citizens, N.A. and the Company dated January 26, 2010 (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 8-K dated January 29, 2010)
14
 
Code of Ethics (Incorporated by reference to Exhibit contained in the Registrant’s Form 10-K/A Amendment No. 2, as filed with the Commission on October 8, 2004)
21
 
Subsidiaries (description incorporated in Form 10-K under Item No. 1)
23.1
 
Consent of Independent Registered Public Accounting Firm, Blackman Kallick, LLP
31.1
 
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith)
31.2
 
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith)
32
 
Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith)

(a)
The Exhibits listed in subparagraph (a)(3) of this Item 15 are attached hereto unless incorporated by reference to a previous filing.
(b)
The Schedule listed in subparagraph (a)(2) of this Item 15 is attached hereto.

 
31

 

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act the Registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized on March 29, 2010.

CTI INDUSTRIES CORPORATION
By:  
/s/ Howard W. Schwan
 
Howard W. Schwan, President

In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

Signatures
 
Title
 
Date
         
/s/ Howard W. Schwan
 
President and Director
 
March 29, 2010
Howard W. Schwan
       
         
/s/ John H. Schwan
 
Chairman and Director
 
March 29, 2010
John H. Schwan
       
         
/s/ Stephen M. Merrick
 
Executive Vice President,
 
March 29, 2010
Stephen M. Merrick
 
Secretary, Chief Financial Officer and Director
   
         
/s/ Stanley M. Brown
 
Director
 
March 29, 2010
Stanley M. Brown
       
         
/s/ Bret Tayne
 
Director
 
March 29, 2010
Bret Tayne
       
         
/s/ John I. Collins
 
Director
 
March 29, 2010
John I. Collins
       
         
/s/ Phil Roos
 
Director
 
March 29, 2010
       

 
32

 

EXHIBIT INDEX

Exhibit
   
Number
 
Document
     
3.1
 
Third Restated Certificate of Incorporation of CTI Industries Corporation (Incorporated by reference to Exhibit A contained in Registrant’s Schedule 14A Definitive Proxy Statement for solicitation of written consent of shareholders, as filed with the Commission on October 25, 1999)
3.2
 
By-Laws of CTI Industries Corporation (Incorporated by reference to Exhibits, contained in Registrant’s Form SB-2 Registration Statement (File No. 333-31969) effective November 5, 1997)
4.1
 
Form of CTI Industries Corporation’s common stock certificate (Incorporated by reference to Exhibits, contained in Registrant’s Form SB-2 Registration Statement (File No. 333-31969) effective November 5, 1997)
10.1
 
CTI Industries Corporation 1999 Stock Option Plan (Incorporated by reference to Exhibit contained in Registrant’s Schedule 14A Definitive Proxy Statement, as filed with the Commission on March 26, 1999)
10.2
 
CTI Industries Corporation 2001 Stock Option Plan (Incorporated by reference to Exhibit contained in Registrant’s Schedule 14A Definitive Proxy Statement, as filed with the Commission on May 21, 2001)
10.3
 
CTI Industries Corporation 2002 Stock Option Plan (Incorporated by reference to Exhibit contained in Registrant’s Schedule 14A Definitive Proxy Statement, as filed with the Commission on May 15, 2002)
10.4
 
CTI Industries Corporation 2007 Stock Incentive Plan (Incorporated by reference to Exhibit contained in Registrant’s Schedule 14A Definitive Proxy Statement, as filed with the Commission on April 30, 2007)
10.5
 
Employment Agreement dated June 30, 1997, between CTI Industries Corporation and Howard W. Schwan (Incorporated by reference to Exhibits, contained in Registrant’s Form SB-2 Registration Statement (File No. 333-31969) effective November 5, 1997.)
10.6
 
Warrant dated July 17, 2001 to purchase 79,364 shares of Common Stock John H. Schwan (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)
10.7
 
Warrant dated July 17, 2001 to purchase 39,683 shares of Common Stock Stephen M. Merrick (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)

 
33

 

10.8
 
Note dated January 28, 2003, CTI Industries Corporation to Stephen M. Merrick in the sum of $500,000 (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)
10.9
 
Note dated February 28, 2003, CTI Industries Corporation to Stephen M. Merrick in the sum of $200,000 (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)
10.10
 
Note dated February 10, 2003, CTI Industries Corporation to John H. Schwan in the sum of $150,000 (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)
10.11
 
Note dated February 15, 2003, CTI Industries Corporation to John Schwan in the sum of $680,000 (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)
10.12
 
Note dated March 3, 2003, CTI Industries Corporation to John H. Schwan in the sum of $100,000 (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)
10.13
 
Warrant dated March 20, 2003, to purchase 70,000 shares of Common Stock - Stephen M. Merrick (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)
10.14
 
Warrant dated March 20, 2003, to purchase 93,000 shares of Common Stock - John H. Schwan (Incorporated by reference to Exhibits contained in the Registrant’s 2002 10-KSB, as filed with the Commission on May 1, 2003)
10.15
 
Loan and Security Agreement between RBS Citizens, N.A. and the Company dated February 1, 2006 (Incorporated by reference to Exhibits contained in Registrant’s Report on Form 8-K dated February 3, 2006)
10.16
 
Warrant dated February 1, 2006, to purchase 151,515 shares of Common Stock - John H. Schwan (Incorporated by reference to Exhibits contained in Registrant’s Report on Form 8-K dated February 3, 2006)
10.17
 
Warrant dated February 1, 2006, to purchase 151,515 shares of Common Stock – Stephen M. Merrick (Incorporated by reference to Exhibits contained in Registrant’s Report on Form 8-K dated February 3, 2006)
10.18
 
Note dated February 1, 2006, CTI Industries Corporation to John Schwan in the sum of $500,000 (Incorporated by reference to Exhibits contained in Registrant’s Report on Form 8-K dated February 3, 2006)

 
34

 

10.19
 
Note dated February 1, 2006, CTI Industries Corporation to Stephen M. Merrick in the sum of $500,000 (Incorporated by reference to Exhibits contained in Registrant’s Report on Form 8-K dated February 3, 2006)
10.20
 
Production and Supply Agreement between ITW Spacebag and the Company dated March 17, 2006 (Incorporated by reference to Exhibits contained in Registrant’s Report on Form 8-K dated March 17, 2006)
10.21
 
License Agreement between Rapak, LLC and the Company dated April 28, 2006 (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 8-K dated May 3, 2006)
10.22
 
Second Amendment to Loan Agreement between RBS Citizens, N.A. and the Company dated December 18, 2006 (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 8-K dated December 21, 2006.)
10.23
 
Third Amendment to Loan Agreement between RBS Citizens, N.A. and the Company dated November 13, 2007 (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 10-Q dated November 13, 2007)
10.24
 
CTI Industries Corporation Incentive Compensation Plan (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 8-K dated October 2, 2007)
10.25
 
Supply and License Agreement among Registrant and S.C. Johnson & Son, Inc. dated February 1, 2008 (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 8-K/A dated March 19, 2008)
10.26
 
Agreement between Babe Winkelman Productions Inc and the Company dated April 10, 2008 (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 8-K dated April 14, 2008)
10.27
 
Amendment to the License Agreement between Rapak, LLC and the Company dated May 6, 2008 (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 8-K dated May 8, 2008)
10.28
 
Fifth Amendment to Loan Agreement between RBS Citizens, N.A. and the Company dated January 30, 2009 (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 8-K dated February 2, 2009)
10.29
 
Sixth Amendment to Loan Agreement between RBS Citizens, N.A. and the Company dated January 26, 2010 (Incorporated by reference to Exhibit contained in Registrant’s Report on Form 8-K dated January 29, 2010)
14
 
Code of Ethics (Incorporated by reference to Exhibit contained in the Registrant’s Form 10-K/A Amendment No. 2, as filed with the Commission on October 8, 2004)
21
 
Subsidiaries (description incorporated in Form 10-K under Item No. 1)

 
35

 

23.1
 
Consent of Independent Registered Public Accounting Firm, Blackman Kallick, LLP
31.1
 
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith)
31.2
 
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith)
32
 
Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith)

 
36

 
CTI Industries Corporation
and Subsidiaries

Consolidated Financial Statements

Years ended December 31, 2009 and 2008

Contents

Consolidated Financial Statements:
 
Report of Independent Registered Public Accounting Firm
F-1
Consolidated Balance Sheets as of December 31, 2009 and 2008
F-2
Consolidated Statements of Operations for the years ended December 31, 2009 and 2008
F-3
Consolidated Statements of Stockholders’ Equity and Comprehensive  Income (Loss) for the years ended December 31, 2009 and 2008
F-4
Consolidated Statements of Cash Flows for the years ended December 31, 2009 and 2008
F-5
Notes to Consolidated Financial Statements for the years ended December 31, 2009 and 2008
F-6
   
Financial Statement Schedule:
 
Schedule II – Valuation and Qualifying Accounts for the years ended December 31, 2009 and 2008
F-30

All other schedules for which a provision is made in the applicable accounting regulation of the Securities and Exchange Commission are not required under the related instructions or are inapplicable and, therefore, have been omitted.

 
 

 
 
Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders
CTI Industries Corporation

We have audited the accompanying consolidated balance sheets of CTI Industries Corporation and Subsidiaries (the “Company”) as of December 31, 2009 and 2008, and the related consolidated statements of operations, stockholders’ equity and comprehensive income (loss) and cash flows for the years then ended. Our audits also included the financial statement schedule listed in the Index at item 15(a). These consolidated financial statements and consolidated schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements and consolidated schedule based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company has determined that it is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
 
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of CTI Industries Corporation and Subsidiaries as of December 31, 2009 and 2008, and the results of their operations and their cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America.  Also, in our opinion, the related consolidated financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.

/s/ Blackman Kallick, LLP
Chicago, Illinois
March 29, 2010
 
F-1

 
Consolidated Balance Sheets

   
December 31, 2009
   
December 31, 2008
 
ASSETS
           
Current assets:
           
Cash and cash equivalents
  $ 870,446     $ 180,578  
Accounts receivable, (less allowance for doubtful accounts of $57,000 and $39,000, respectively)
   
7,320,181
     
                 5,821,593
 
Inventories, net
    9,643,914       10,504,769  
Net deferred income tax asset
    706,754       674,872  
Prepaid expenses and other current assets
    607,127       506,225  
                 
Total current assets
    19,148,422       17,688,037  
                 
Property, plant and equipment:
               
Machinery and equipment
    22,390,891       21,612,995  
Building
    3,183,795       3,179,909  
Office furniture and equipment
    2,677,476       1,898,642  
Intellectual property
    345,092       345,092  
Land
    250,000       250,000  
Leasehold improvements
    428,864       409,797  
Fixtures and equipment at customer locations
    2,541,881       2,539,033  
Projects under construction
    270,131       1,017,737  
      32,088,130       31,253,205  
Less : accumulated depreciation and amortization
    (22,554,719 )     (20,677,223 )
                 
Total property, plant and equipment, net
    9,533,411       10,575,982  
                 
Other assets:
               
Deferred financing costs, net
    11,846       123,229  
Goodwill
    989,108       989,108  
Net deferred income tax asset
    361,457       341,714  
Other assets (due from related party $79,000 and $63,000, respectively)
    351,065       270,121  
                 
Total other assets
    1,713,476       1,724,172  
                 
TOTAL ASSETS
    30,395,309       29,988,191  
                 
LIABILITIES AND EQUITY
               
Current liabilities:
               
Checks written in excess of bank balance
    735,257       680,348  
Trade payables
    3,236,607       3,153,005  
Line of credit
    7,598,671       7,960,765  
Notes payable - current portion
    1,111,307       1,091,489  
Notes payable - officers, current portion, net of debt discount of $89,000 and $89,000, respectively
    1,368,964       1,363,255  
Accrued liabilities
    2,683,714       1,973,318  
                 
Total current liabilities
    16,734,520       16,222,180  
                 
Long-term liabilities:
               
Notes Payable - Affiliates
    780,087       894,620  
Notes payable, net of current portion
    3,108,849       4,220,071  
Notes payable - officers, subordinated, net of debt discount of $7,000 and $96,000, respectively
    992,632       903,964  
Total long-term liabilities
    4,881,568       6,018,655  
                 
Equity:
               
CTI Industries Corporation stockholders' equity:
               
Preferred Stock — no par value 2,000,000 shares  authorized 0 shares issued and outstanding
  $ -     $ -  
Common stock  - no par value, 5,000,000 shares authorized, 2,808,720 and 2,808,720 shares issued and 2,738,063 and 2,808,720 outstanding, respectively
    3,764,020       3,764,020  
Paid-in-capital
    8,693,946       8,703,265  
Warrants issued in connection with subordinated debt and bank debt
    443,313       443,313  
Accumulated deficit
    (2,206,728 )     (3,209,868 )
Accumulated other comprehensive loss
    (1,803,442 )     (1,966,130 )
Less:  Treasury stock, 70,657 shares and 0 shares, respectively
    (128,446 )     -  
                 
Total CTI Industries Corporation stockholders' equity
    8,762,663       7,734,600  
                 
Noncontrolling interest
    16,558       12,756  
                 
Total Equity
    8,779,221       7,747,356  
                 
TOTAL LIABILITIES AND EQUITY
  $ 30,395,309     $ 29,988,191  

See accompanying notes to consolidated financial statements

 
F-2

 

CTI Industries Corporation and Subsidiaries
Consolidated Statements of Income

   
For the Year Ended December 31,
 
   
2009
   
2008
 
Net Sales
  $ 41,295,152     $ 44,980,674  
                 
Cost of Sales
    32,081,779       34,658,271  
                 
Gross profit
    9,213,373       10,322,403  
                 
Operating expenses:
               
General and administrative
    4,539,494       5,375,526  
Selling
    871,258       886,391  
Advertising and marketing
    1,576,225       1,677,900  
                 
Total operating expenses
    6,986,977       7,939,817  
                 
Income from operations
    2,226,396       2,382,586  
                 
Other (expense) income:
               
Interest expense
    (1,102,662 )     (1,037,136 )
Interest income
    17,555       5,679  
Foreign currency (loss) gain
    (19,956 )     50,003  
                 
Total other expense, net
    (1,105,063 )     (981,454 )
                 
Income before taxes
    1,121,333       1,401,132  
                 
Income tax expense
    114,391       246,779  
                 
Net Income
    1,006,942       1,154,353  
                 
Less: Net income attributable to noncontrolling interest
    3,802       222  
                 
Net income attributable to CTI Industries Corporation
  $ 1,003,140     $ 1,154,131  
                 
Other Comprehensive Income, net of taxes
               
Unrealized gain (loss) on derivative instruments
  $ 152,830     $ (241,809 )
Foreign currency adjustment
  $ 9,858     $ (1,123,038 )
Comprehensive income (loss) attributable to CTI Industries Corporation
  $ 1,165,828     $ (210,716 )
                 
Basic income per common share
  $ 0.36     $ 0.42  
                 
Diluted income per common share
  $ 0.36     $ 0.40  
                 
Weighted average number of shares and equivalent shares of common stock outstanding:
               
Basic
    2,765,277       2,763,017  
                 
Diluted
    2,775,062       2,898,681  

See accompanying notes to consolidated financial statements

 
F-3

 

CTI Industries Corporation and Subsidiaries
Consolidated Statements of Stockholders' Equity and Comprehensive Income (Loss)

   
CTI Industries Corporation
             
                     
Value of warrants
         
Accumulated
                         
                     
issued in
         
Other
   
Less
             
   
Common Stock
   
Paid-in
   
connection with
   
Accumulated
   
Comprehensive
   
Treasury Stock
   
Noncontrolling
       
   
Shares
   
Amount
   
Capital
   
subordinated debt
   
Deficit
   
Loss
   
Shares
   
Amount
   
Interest
   
TOTAL
 
                                                             
Balance, December 31, 2007
    2,569,124     $ 3,764,020     $ 6,754,077     $ 1,038,487     $ (4,363,999 )   $ (601,283 )     -     $ -     $ 12,534     $ 6,603,836  
                                                                                 
Warrants Exercised
    163,000             $ 793,810                                                     $ 793,810  
                                                                                 
Options Exercised
    8,357             $ 16,775                                                     $ 16,775  
                                                                                 
Issue of warrants related to loan guarantee
                  $ 126,371                                                     $ 126,371  
                                                                                 
Shares issued under SEDA agreement (net of issuance costs)
    18,239             $ 94,500                                                     $ 94,500  
                                                                                 
Reclass  exercised warrants issued with debt
                  $ 595,174     $ (595,174 )                                           $ -  
                                                                                 
Stock issued for services
    50,000             $ 235,188                                                     $ 235,188  
                                                                                 
Compensation relating to Option Issuance
                  $ 58,061                                                     $ 58,061  
                                                                                 
Excess tax benefit - Options
                  $ 29,309                                                     $ 29,309  
                                                                                 
Net Income
                                  $ 1,154,131                             $ 222     $ 1,154,353  
                                                                                 
Other comprehensive income,  net of taxes
                                                                               
Unrealized loss on derivative instruments
                                          $ (241,809 )                           $ (241,809 )
Foreign currency translation
                                          $ (1,123,038 )                           $ (1,123,038 )
Total comprehensive loss
                                                                          $ (210,494 )
                                                                                 
Balance, December 31, 2008
    2,808,720       3,764,020     $ 8,703,265     $ 443,313     $ (3,209,868 )   $ (1,966,130 )     -       -       12,756     $ 7,747,356  
                                                                                 
Adjustment to stock issued for services in the prior year
                  $ (96,688 )                                                   $ (96,688 )
                                                                                 
Compensation relating to Option Issuance
                  $ 87,369                                                     $ 87,369  
                                                                                 
Stock Buybacks
                                                    (70,657 )   $ (128,446 )           $ (128,446 )
                                                                                 
Net Income
                                  $ 1,003,140                             $ 3,802     $ 1,006,942  
                                                                                 
Other comprehensive income,  net of taxes
                                                                               
Unrealized loss on derivative instruments
                                          $ 152,830                             $ 152,830  
Foreign currency translation
                                          $ 9,858                             $ 9,858  
Total comprehensive income
                                                                          $ 1,169,630  
                                                                                 
Balance, December 31, 2009
    2,808,720       3,764,020     $ 8,693,946     $ 443,313     $ (2,206,728 )   $ (1,803,442 )     (70,657 )     (128,446 )     16,558     $ 8,779,221  

See accompanying notes to consolidated financial statements

 
F-4

 

CTI Industries Corporation and Subsidiaries
Consolidated Statements of Cash Flows

   
For the Year Ended December 31,
 
   
2009
   
2008
 
             
Cash flows from operating activities:
           
Net income
  $ 1,006,942     $ 1,154,353  
Adjustment to reconcile net income to cash provided by operating activities:
               
Depreciation and amortization
    1,958,296       1,592,891  
Amortization of debt discount
    88,668       88,668  
Stock based compensation
    87,369       58,061  
Excess tax benefits from stock based compensation
    -       (12,801 )
Provision for losses on accounts receivable
    65,380       138,657  
Provision for losses on inventories
    25,126       178,288  
Deferred income taxes
    (8,947 )     218,080  
Change in assets and liabilities:
               
Accounts receivable
    (1,411,267 )     (587,572 )
Inventories
    948,311       (1,380,459 )
Prepaid expenses and other assets
    (282,618 )     191,606  
Trade payables
    47,880       (783,752 )
Accrued liabilities
    587,648       (455,409 )
                 
Net cash provided by operating activities
    3,112,788       400,611  
                 
                 
Cash used in investing activity - purchases of property, plant and equipment
    (731,596 )     (2,200,454 )
                 
Net cash used in investing activity
    (731,596 )     (2,200,454 )
                 
Cash flows from financing activities:
               
Change in checks written in excess of bank balance
    53,554       79,838  
Net change in revolving line of credit
    (362,095 )     1,214,552  
Proceeds from issuance of long-term debt and warrants
    -       1,224,267  
Repayment of long-term debt (related parties $140,000 and  $117,000)
    (1,250,520 )     (942,436 )
Excess tax benefits from stock-based compensation
    -       12,801  
Proceeds from exercise of stock options
    -       16,775  
Proceeds from issuance of stock
    -       94,500  
Cash paid for purchase of stock
    (128,446 )     -  
Cash paid for deferred financing fees
    (40,556 )     (19,425 )
                 
Net cash (used in) provided by financing activities
    (1,728,063 )     1,680,872  
                 
Effect of exchange rate changes on cash
    36,739       (183,564 )
                 
Net increase (decrease) in cash and cash equivalents
    689,868       (302,535 )
                 
Cash and cash equivalents at beginning of period
    180,578       483,113  
                 
Cash and cash equivalents at end of period
  $ 870,446     $ 180,578  
                 
Supplemental disclosure of cash flow information:
               
Cash payments for interest
  $ 988,001     $ 1,039,433  
                 
Cash payments for taxes
  $ 148,095     $ 90,206  
                 
Supplemental Disclosure of non-cash investing and financing activity
               
Stock issued under consulting agreement
  $ 69,063     $ 69,437  
                 
Exercise of Warrants and payment of Subordinated Debt
  $ -     $ 793,810  
                 
Issuance of warrants for guarantee of debt
  $ -     $ 126,371  
                 
Property, Plant & Equipment acquisitions funded by liabilities
  $ 101,835     $ 122,757  

See accompanying notes to consolidated  financial statements
 
F-5

 

Notes to Consolidated Financial Statements Years Ended
December 31, 2009 and 2008

1.  Nature of Business

Nature of Operations

CTI Industries Corporation, its United Kingdom subsidiary (CTI Balloons Limited), its Mexican subsidiaries (Flexo Universal, S.A. de C.V., CTI Mexico Corporation, S.A. de C.V. and CTF International S.A. de C.V.), and CTI Helium, Inc. (the “Company”) (i) design, manufacture and distribute metalized and latex balloon products throughout the world and (ii) operate systems for the production, lamination, coating and printing of films used for food packaging and other commercial uses and for conversion of films to flexible packaging containers and other products.

2.  Summary of Significant Accounting Policies

Reclassifications
 
Certain amounts in the 2008 consolidated financial statements have been reclassified to conform to the current period presentation.  In addition, as of January 1, 2009 we adopted a new generally accepted accounting principle related to noncontrolling interest in the consolidated financial statements that required retrospective application, in which all periods presented reflect the necessary changes.
 
Principles of Consolidation
 
The consolidated financial statements include the accounts of CTI Industries Corporation, its wholly owned subsidiaries CTI Balloons Limited, CTF International S.A. de C.V., and CTI Helium, Inc. and its majority owned subsidiaries, Flexo Universal and CTI Mexico Corporation. All significant intercompany accounts and transactions have been eliminated upon consolidation.
 
Foreign Currency Translation
 
The financial statements of foreign subsidiaries are translated into U.S. dollars using the exchange rate at each balance sheet date for assets and liabilities, the historical exchange rate for stockholders’ equity, and a weighted average exchange rate for each period for revenues and expenses. Translation adjustments are recorded in accumulated other comprehensive income (loss) as the local currencies of the subsidiaries are the functional currencies. Foreign currency transaction gains and losses are recognized in the period incurred and are included in the consolidated statements of operations.

 
F-6

 

Use of Estimates
 
In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the amounts reported of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period in the financial statements and accompanying notes. Actual results may differ from those estimates. The Company’s significant estimates include valuation allowances for doubtful accounts, lower of cost or market of inventory, deferred tax assets, and recovery value of goodwill.
 
Cash and Cash Equivalents
 
Cash and cash equivalents include cash on hand, demand deposits and short term investments with original maturities of three months or less.
 
Accounts Receivable
 
Trade receivables are carried at original invoice amount less an estimate for doubtful receivables based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for doubtful accounts by identifying troubled accounts, evaluating the individual customer receivables through consideration of the customer’s financial condition, credit history and current economic conditions and use of historical experience applied to an aging of accounts. A trade receivable is considered to be past due if any portion of the receivable balance is outstanding for a period over the customer’s normal terms. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received.

Inventories
 
Inventories are stated at the lower of cost or market. Cost is determined using standard costs which approximates costing determined on a first-in, first-out basis, to reflect the actual cost of production of inventories.
 
Production costs of work in process and finished goods include material, labor and overhead. Work in process and finished goods are not recorded in excess of net realizable value.

Property, Plant and Equipment
 
Property and equipment are stated at cost. Expenditures for maintenance and repairs are charged to operations as incurred. Depreciation is computed using the straight-line method over estimated useful lives of the related assets. Leasehold improvements are amortized on a straight-line method over the lesser of the estimated useful life or the lease term. The estimated useful lives range as follows:

 
F-7

 

Building
 
25 - 30 years
Machinery and equipment
 
3 - 15 years
Projects that prolong the life and increase efficiency of machinery
 
3 - 5 years
Light Machinery
 
5 - 10 years
Heavy Machinery
 
10 - 15 years
Office furniture and equipment
 
5 - 8 years
Leasehold improvements
 
5 - 8 years
Furniture and equipment at customer locations
 
1 - 3 years

Light machinery consists of forklifts, scissor lifts, and other warehouse machinery.  Heavy machinery consists of production equipment including laminating, printing and converting equipment.  Projects in process represent those costs capitalized in connection with construction of new assets and/or improvements to existing assets including a factor for interest on funds committed to projects in process of $31,000 and $74,000 for the years ended December 31, 2009 and 2008, respectively.  Upon completion, these costs are reclassified to the appropriate asset class.
 
Stock-Based Compensation

The Company has stock-based incentive plans which may grant stock option, restricted stock, and unrestricted stock awards.  The Company recognizes stock-based compensation expense based on the grant date fair value of the award and the related vesting terms.  The fair value of stock-based awards is determined using the Black-Scholes model, which incorporates assumptions regarding the risk-free interest rate, expected volatility, expected option life, and dividend yield.  See Note 17 for additional information.

Fair Value Measurements

FASB GAAP USA defines fair value, establishes a framework for measuring fair value, and requires disclosures about fair value measurements required under other accounting pronouncements.  See Note 4 for further discussion.

Goodwill
 
The Company applies the provisions of FASB GAAP USA, under which goodwill is tested at least annually for impairment. Goodwill on the accompanying balance sheets relates to the Company’s acquisition of Flexo Universal in a prior year. It is the Company’s policy to perform impairment testing for Flexo Universal annually as of December 31, or as circumstances change.  An annual impairment review was completed and no impairment was noted for the years ended December 31, 2009 and 2008.  (See Note 15)  While the Company believes that its estimates of future cash flows are reasonable, different assumptions regarding such cash flows could materially affect these evaluations.

 
F-8

 

Valuation of Long Lived Assets
 
The Company evaluates whether events or circumstances have occurred which indicate that the carrying amounts of long-lived assets (principally property, plant and equipment) may be impaired or not recoverable. The significant factors that are considered that could trigger an impairment review include: changes in business strategy, market conditions, or the manner of use of an asset; underperformance relative to historical or expected future operating results; and negative industry or economic trends. In evaluating an asset for possible impairment, management estimates that asset’s future undiscounted cash flows and appraised values to measure whether the asset is recoverable, the Company measures the impairment based on the projected discounted cash flows of the asset over its remaining life.
 
Deferred Financing Costs
 
Deferred financing costs are amortized on a straight line basis over the term of the loan. Upon a refinancing, existing unamortized deferred financing costs are expensed.

Income Taxes
 
The Company accounts for income taxes using the liability method. As such, deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial reporting purposes and the amount used for income tax purposes. Deferred tax assets and liabilities are measured using enacted tax rates expected to be in effect when the anticipated reversal of these differences is scheduled to occur. Deferred tax assets are reduced by a valuation allowance when, management cannot determine, in its opinion, that it is more likely than not that the Company will recover that recorded value of the deferred tax asset. The Company is subject to U.S. Federal, state and local taxes as well as foreign taxes in the United Kingdom and Mexico.

Unrecognized tax benefits are accounted for as required by FASB GAAP USA which prescribes a more likely than not threshold for financial statement presentation and measurement of a tax position taken or expected to be taken in a tax return.  See Note 11 for further discussion.
 
Revenue Recognition
 
The Company recognizes revenue when title transfers upon shipment. Revenue from a transaction is not recognized until (i) a definitive arrangement exists, (ii) delivery of the product has occurred or the services have been performed and legal title and risk are transferred to the customer, (iii) the price to the buyer has been fixed or is determinable and (iv) collectability is reasonably assured. In some cases, product is provided on consignment to customers. For these cases, revenue is recognized when the customer reports a sale of the product.

 
F-9

 

Research and Development
 
The Company conducts product development and research activities which include (i) creative product development and (ii) engineering. During the years ended December 31, 2009 and 2008, research and development activities totaled $360,000 and $357,000, respectively.
 
Advertising Costs
 
The Company expenses advertising costs as incurred.  Advertising expenses amounted to $240,000 and $346,000 for the years ended December 31, 2009 and 2008, respectively.

Subsequent Events

Effective June 15, 2009, the Company adopted the provisions of FASB GAAP USA requires entities to evaluate subsequent events through the date the consolidated financial statements are issued.  The Company has determined that no material subsequent events have occurred, except as set forth in Note 21.

3.  New Accounting Pronouncements

In December 2007, the Financial Accounting Standards Board (FASB) issued new accounting guidance on business combinations. The new guidance revises the method of accounting for a number of aspects of business combinations including acquisition costs, contingencies (including contingent assets, contingent liabilities and contingent purchase price), and post-acquisition exit activities of acquired businesses. The Company adopted the new guidance, and the adoption of the new guidance did not have a material effect on our financial position, results of operations or cash flows.

In December 2007, the FASB also issued new accounting guidance on noncontrolling interests in consolidated financial statements. The new accounting guidance requires that a noncontrolling interest in the equity of a subsidiary be accounted for and reported as equity, provides revised guidance on the treatment of net income and losses attributable to the noncontrolling interest and changes in ownership interests in a subsidiary, and requires additional disclosures that identify and distinguish between the interests of the controlling and noncontrolling owners. The Company retrospectively adopted the presentation and disclosure requirements of the new guidance.  The adoption of the new guidance did not have a material effect on our financial position, results of operations or cash flows. Net earnings represent net income attributable to the Company’s common shareholders

In March 2008, the FASB issued new accounting standards that amend and expand the disclosure requirements for derivative instruments and hedging activities, which were effective for fiscal years beginning after November 15, 2008 and interim periods with those fiscal years. These new disclosure requirements became effective for the Company January 1, 2009 and are included in Note 4 of the Company’s consolidated financial statements.

 
F-10

 

In April 2008, the FASB issued new accounting standards relating to factors that should be considered in developing renewal or extension assumptions used to determine the useful life of a recognized intangible asset. These standards became effective prospectively for fiscal years beginning after December 15, 2008 and interim periods within those fiscal years. Any future impact of these standards on the Company’s consolidated financial statements will depend on the number and size of future acquisitions, if any.

In April 2009, the FASB issued new accounting standards for the initial recognition and measurement, subsequent measurement and accounting and disclosure of assets acquired and liabilities assumed arising from contingencies in a business combination. These standards were effective for the first annual reporting period on or after December 31, 2008. Their impact on the Company’s consolidated financial statements will depend on the number and size of acquisition transactions, if any, engaged in by the company in the future.

In May 2009, the FASB issued new accounting standards for subsequent events, which establish general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued. These standards were effective prospectively for interim and annual periods ending after June 15, 2009 and did not have a material impact on the consolidated financial statements.

In June 2009, the FASB issued new accounting standards that amend the evaluation criteria to identify the primary beneficiary of a variable interest entity and require ongoing reassessments of whether an enterprise is the primary beneficiary of the variable interest entity. These accounting standards are effective for annual reporting periods that begin after November 15, 2009 and interim periods within those fiscal years. They are not expected to have a material impact on the Company’s consolidated financial statements.

In June 2009, the FASB established the FASB Accounting Standards Codification (the “Codification” or “ASC”) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with U.S. GAAP. Rules and interpretive releases of the Securities and Exchange Commission (SEC) under authority of federal securities laws are also sources of authoritative GAAP for SEC registrants. The Codification superseded all existing non-SEC accounting and reporting standards, with limited exceptions to allow recently issued non-SEC accounting and reporting standards to be incorporated into the Codification. All other non-grandfathered, non-SEC accounting literature not included in the Codification became non-authoritative.

 
F-11

 

The FASB will no longer issue new standards in the form of Statements, FASB Staff Positions, Emerging Issues Task Force Abstracts, or FASB Interpretations. Instead, it will issue Accounting Standards Updates (“ASU”), which will serve to update the Codification, provide background information about the guidance and provide the basis for conclusions on the changes to the Codification. The Codification was not intended to change GAAP and did not affect the Company’s accounting methods, but it did change the way the accounting standards are organized and presented, particularly in descriptions of significant accounting policies. The Codification is effective for interim and annual periods ending after September 15, 2009.

4.  Fair Value Disclosures; Derivative Instruments

Effective January 1, 2008, the Company adopted the provisions of FASB GAAP USA which clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants.  FASB GAAP USA also requires that a fair value measurement reflect the assumptions market participants would use in pricing an asset or liability based upon the best information available.  In February 2008, the FASB issued guidance now codified in FASB GAAP USA which provides for delayed application of certain guidance related to non-financial assets and non-financial liabilities, except for items that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually).

FASB GAAP USA establishes a three-level valuation hierarchy for disclosure of fair value measurements.  The valuation hierarchy categorizes assets and liabilities at fair value into one of three different levels depending on the observability of the inputs employed in the measurement.  The three levels are defined as follows:

 
·
Level 1 – inputs to the valuation methodology are quoted prices (unadjusted) for identical assets are liabilities in active markets.

 
·
Level 2 – inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs are observable for the asset or liability, or unobservable but corroborated by market data, for substantially the full term of the financial instrument.

 
·
Level 3 – inputs to the valuation methodology are unobservable and significant to the fair value measurement.

A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of the input that is significant to the fair value measurement.  The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.  The following tables presents information about the Company’s liabilities measured at fair value on a recurring basis as of December 31, 2009 and 2008 and indicates the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value:

 
F-12

 


   
Amount as of
                   
Description
 
12/31/2009
   
Level 1
   
Level 2
   
Level 3
 
Interest Rate Swap 2006-1
  $ (16,000 )           $ (16,000 )        
Interest Rate Swap 2006-2
    (81,000 )             (81,000 )        
Interest Rate Swap 2008
    (92,000 )             (92,000 )        
    $ (189,000 )           $ (189,000 )        

   
Amount as of
                   
Description
 
12/31/2008
   
Level 1
   
Level 2
   
Level 3
 
Interest Rate Swap 2006-1
  $ (49,929 )           $ (49,929 )        
Interest Rate Swap 2006-2
    (142,351 )             (142,351 )        
Interest Rate Swap 2008
    (149,165 )             (149,165 )        
    $ (341,445 )           $ (341,445 )        

The Company’s interest rate swap agreements are valued using the counterparty’s mark-to-market statement, which can be validated using modeling techniques that include market inputs such as publically available interest rate yield curves, and are designated as Level 2 within the valuation hierarchy.

FASB GAAP USA requires an entity to recognize all derivatives as either assets or liabilities in the consolidated balance sheet and to measure those instruments at fair value.  Under certain conditions, a derivative may be specifically designated as a fair value hedge or a cash flow hedge.

On April 5, 2006, the Company entered into two swap agreements with RBS Citizens N.A. (“RBS”) in connection with portions (original notional amount totaling $3,780,000) of the principal amounts of a mortgage loan and term loan to the Company fixing the interest rate on such floating rate loans from prime plus 0.75% to 8.49%.  The remaining notional amount at December 31, 2009 and 2008 was $1,953,000 and $2,440,000, respectively.  On January 28, 2008, the Company entered into an additional swap agreement with RBS with respect to a $3,000,000 notional amount of a floating rate revolving loan, fixing the interest rate on such amount from prime plus 0.75% to 6.17%.  The remaining notional amount relating to this swap was $3,000,000 at December 31, 2009 and 2008.  These swap agreements are designated as cash flow hedges and hedge the Company’s exposure to interest rate fluctuations on the portions of the principal amount of loans with RBS that are covered by the swap agreements.  These swap agreements are derivative financial instruments and the Company determines the fair market value of these agreements on a quarterly basis, based on RBS’s mark-to-market statement, recording the fair market value of these contracts on the balance sheet with the offset to other comprehensive loss.  As of December 31, 2009, the Company has recorded the fair value of these swap agreements on the balance sheet as a liability of $189,000.  For the quarter and year ended December 31, 2009, the Company recorded unrealized gains of $40,000 and $153,000, and for the quarter and year ended December 31, 2008, the Company recorded an unrealized loss of $162,000 and $242,000, respectively with respect to these swap agreements in other comprehensive income, which represents the change in value of these swap agreements for the quarter and year then ended.

 
F-13

 

The Company has not had any realized loss from financial instruments during 2009 and 2008.

As a result of the use of derivative instruments, the Company is exposed to risk that the counterparty may fail to meet their contractual obligations.  Recent adverse developments in the global financial and credit markets could negatively impact the creditworthiness of our counterparty and cause them to fail to perform as expected.  To mitigate the counterparty credit risk, we have only entered into contracts with a major financial institution based upon their credit ratings and other factors, and continually assess the creditworthiness of the counterparty.  To date, the counterparty has performed in accordance with their contractual obligations.

5.  Other Comprehensive Loss

The following table sets forth the tax effects of components of other comprehensive loss and the accumulated balance of other comprehensive loss and each component.
 
Tax Effects Allocated to Each Component of Other Comprehensive Income (Loss) for the years ended December 31, 2009 and 2008

         
Tax
       
   
Before-Tax
   
(Expense)
   
Net-of-Tax
 
   
Amount
   
or Benefit
   
Amount
 
2009
                 
Foreign currency translation adjustments
  $ 9,858     $ -     $ 9,858  
Unrealized gain on derivative instruments
    152,830       -       152,830  
Other comprehensive income
  $ 162,688     $ -     $ 162,688  
                         
           
Tax
         
   
Before-Tax
   
(Expense)
   
Net-of-Tax
 
   
Amount
   
or Benefit
   
Amount
 
2008
                       
Foreign currency translation adjustments
  $ (1,123,038 )   $ -     $ (1,123,038 )
Unrealized loss on derivative instruments
    (241,809 )     -       (241,809 )
Other comprehensive loss
  $ (1,364,847 )   $ -     $ (1,364,847 )
                         
Accumulated Other Comprehensive Loss Balances as December 31, 2009
       
         
                   
Accumulated
 
   
Foreign
   
Unrealized
   
Other
 
   
Currency
   
Loss on
   
Comprehensive
 
   
Items
   
Derivatives
   
Income
 
Beginning balance
  $ (1,624,685 )   $ (341,445 )   $ (1,966,130 )
Current period change, net of tax
    9,858       152,830       162,688  
Ending balance
  $ (1,614,827 )   $ (188,615 )   $ (1,803,442 )
 
 
F-14

 

Accumulated Other Comprehensive Loss Balances as December 31, 2008
       
         
               
Accumulated
 
   
Foreign
   
Unrealized
   
Other
 
   
Currency
   
Loss on
   
Comprehensive
 
   
Items
   
Derivatives
   
Income
 
Beginning balance
  $ (501,647 )   $ (99,636 )   $ (601,283 )
Current period Change, net of tax
    (1,123,038 )     (241,809 )     (1,364,847 )
Ending balance
  $ (1,624,685 )   $ (341,445 )   $ (1,966,130 )

For the years ended December 31, 2009 and 2008 no tax benefit for foreign currency translation adjustments has been recorded as such amounts would result in a deferred tax asset. For the years ended December 31, 2009 and 2008 no income tax benefit was recorded for the unrealized losses on the derivative instruments by reason of the fact that the tax benefit was offset by the valuation allowance with respect to the related deferred tax asset.

6.  Major Customers

For the year ended December 31, 2009, the Company had three customers that accounted for approximately 27.7%, 15.4% and 11.1%, respectively, of consolidated net sales. In 2008, the top three customers accounted for approximately 20.0%, 16.9%, and 15.5%, respectively.  At December 31, 2009, the outstanding accounts receivable balances due from these three customers were $2,783,000, $574,000 and $813,000, respectively. At December 31, 2008, the outstanding accounts receivable balances due from these customers were $2,155,000, $311,000, and $144,000, respectively.

7.  Inventories

Inventories are stated at the lower of cost or market. Cost is determined using standard costs which approximate costing determined on a first-in, first out basis. Standard costs are reviewed and adjusted periodically and at year end based on actual direct and indirect production costs. On a periodic basis, the Company reviews its inventory levels for estimated obsolescence or unmarketable items, in reference to future demand requirements and shelf life of the product.
 
 Inventories are comprised of the following:

   
December 31,
   
December 31,
 
   
2009
   
2008
 
Raw materials
  $ 1,520,000     $ 1,676,000  
Work in process
    442,000       1,075,000  
Finished goods
    8,024,000       8,183,000  
Allowance for excess quantities
    (342,000 )     (429,000 )
Total inventories
  $ 9,644,000     $ 10,505,000  
 
 
F-15

 

8. Notes Payable 
 
Long term debt consists of:
 
   
Dec. 31, 2009
   
Dec. 31, 2008
 
Term Loan with RBS, payable in monthly installments of $58,333 plus interest at prime (3.25% at December 31, 2009 and 2008) plus 0.75% (4.00%) and 0.50% (3.75%) at December 31, 2009 and 2008, respectively (amortized over 60 months) balance due January 31, 2011
  $ 817,000     $ 1,517,000  
                 
Mortgage Loan with RBS, payable in monthly installments of $9,333 plus interest at prime (3.25% at December 31, 2009 and 2008) plus 0.75% (4.00%) and 0.50% (3.75%) at December 31, 2009 and 2008, respectively (amortized over 25 years) balance of $2,300,000 due January 31, 2011
  $ 2,371,000     $ 2,481,000  
                 
(2009) Asset Financing Loans (Forklift financed with Yale Financial Services; Pouch Machines financed with RBS): Forklift payable in monthly installments of $574 (amortized over 5 years); Pouch Machine #6; payable in monthly installments of $5,626 (amortized over 5 years); Pouch Machine #7, 8; payable in monthly installments of $9,891 (amortized over 5 years); Pouch Machine #9, 10,11; payable in monthly installments of $14,111 (amortized over 5 years); (2008) Asset Financing Loans (Forklift financed with Yale Financial Services; Pouch Machines financed with RBS): Forklift payable in monthly installments of $426 (amortized over 5 years); Pouch Machine #6; payable in monthly installments of $5,626 (amortized over 5 years); Pouch Machine #7, 8; payable in monthly installments of $9,891 (amortized over 5 years); Pouch Machine #9, 10,11; payable in monthly installments of $14,111 (amortized over 5 years)
    1,033,000       1,314,000  
                 
Subordinated Notes (Officers) due on demand, interest at 9%  (See Notes  10, 14)
  $ 638,000     $ 638,000  
                 
Subordinated Notes (Officers) due on demand, interest at 8% (See Notes 10, 14)
  $ 814,000     $ 814,000  
                 
Subordinated Notes (Officers) due 2011, interest at prime (3.25% at December 31, 2009 and 2008) plus 2%, 5.25% as of December 31, 2009 and 2008, net of debt discount of $96,000 and  $185,000 at December 31, 2009 and 2008, respectively
  $ 904,000     $ 815,000  
                 
Notes Payable (Affiliates) due 2013, interest at 8.5%
  $ 659,000     $ 858,000  
                 
Notes Payable (Affiliates) due 2021, interest at 11.75%
  $ 126,000     $ 36,000  
                 
Total long-term debt
  $ 7,362,000     $ 8,473,000  
                 
Less current portion
  $ (2,480,000 )   $ (2,174,000 )
                 
Total Long-term debt, net of current portion
  $ 4,882,000     $ 6,299,000  
 
 
F-16

 

On February 1, 2006, the Company entered into a Loan Agreement with RBS Citizens N.A. (“RBS”), Chicago, Illinois, previously referred to as Charter One Bank, under which, as amended, RBS has agreed to provide a credit facility to the Company in the total amount of $15,300,000, which includes (i) a five year mortgage loan secured by the Barrington, Illinois property in the principal amount of $2,800,000, amortized over a 25 year period, (ii) a five year term loan secured by the equipment at the Barrington, Illinois plant in the amount of $3,500,000 and (iii) a three-year revolving line of credit up to a maximum amount of $9,000,000, secured by inventory and receivables. The amount the Company can borrow on the revolving line of credit includes 85% of eligible receivables and 60% of eligible inventory.  Certain terms of the loan agreement include:

 
·
Restrictive Covenants:  The Loan Agreement includes several restrictive covenants under which we are prohibited from, or restricted in our ability to:
 
o
Borrow money;
 
o
Pay dividends and make distributions;
 
o
Issue stock;
 
o
Make certain investments;
 
o
Use assets as security in other transactions;
 
o
Create liens;
 
o
Enter into affiliate transactions;
 
o
Merge or consolidate; or
 
o
Transfer and sell assets.

 
·
Financial Covenants:  The loan agreement includes a series of financial covenants we are required to meet including:
 
o
We are required to maintain a tangible net worth in excess of $3,500,000;
 
o
We are required to maintain specified ratios of senior debt to EBITDA on an annual basis and determined quarterly commencing as of June 30, 2006; and,
 
o
We are required to maintain a specified level of EBITDA to fixed charges for the six months ending June 30, 2006, the nine months ending September 30, 2006 and twelve months thereafter.

As of December 31, 2009, the Company was in compliance with these covenants.  On January 26, 2010, the Company entered into an amendment to the Loan Agreement extending the revolving loan term to April 30, 2010.  Management expects that a similar agreement with RBS or with another lender will be obtained in the future.

The Company used interest rate swaps as a cash flow hedge to manage interest costs and the risk associated with changing interest rates of long-term debt.  (See Note 4)

John H. Schwan and Stephen M. Merrick both as officers, directors and principal shareholders of the Company have each personally guaranteed the obligations of the Company to RBS up to $2,000,000.  (See Note 14)

 
F-17

 

As of December 31, 2009 the balance outstanding on the revolving line of credit with RBS was $7,599,000 with respect to which $3,000,000 covered by the swap agreement bears interest of 6.17% and the balance bears  interest of 4.00%.
 
Future minimum principal payments, exclusive of debt discount, for amounts outstanding under these long-term debt agreements for each of the years ended December 31:
 
2010
  $ 2,480,000  
2011
    4,047,000  
2012
    554,000  
2013
    193,000  
2014
    17,000  
Thereafter
    71,000  
Total
  $ 7,362,000  
 
9. Current Liabilities

As of December 31, 2009, Accrued Liabilities includes $776,000 in payroll accruals and $189,000 in mark to market liabilities.  As of December 31, 2008, Accrued Liabilities includes $1,147,000 in accruals and $341,000 in mark to market liabilities.

10. Subordinated Debt
 
In February 2003, the Company received $1,630,000 from certain shareholders in exchange for (a) 9% subordinated notes, and (b) five year warrants to purchase 163,000 common shares at $4.87 per share. The proceeds were to (i) re-finance the bank loan of CTI Mexico in the amount of $880,000 and (ii) to provide financing for CTI Mexico and Flexo Universal. The value of the warrants was $460,000 calculated using Black-Scholes option pricing formula. The Company applied the discount against the subordinated debt. The discount is being amortized using the effective interest method to interest expense over the term of the debt. These loans are subordinated to the Bank debt of the Company.  On February 8, 2008 those shareholders exercised these warrants in exchange for a reduction on these notes of $794,000.  The remaining balance of $638,000 is due on demand.
 
In February 2006, the Company received $1,000,000 from certain shareholders in exchange for (a) five year subordinated notes bearing interest at 2% over the prime rate determined on a quarterly basis, and (b) five year warrants to purchase an aggregate of 303,030 shares of common stock of the Company at the price of $3.30 per share. The proceeds were to fund capital improvements and give additional liquidity to the Company.  The value of the warrants was $443,000 using the Black-Scholes option pricing formula. The Company applied the discount against the subordinated debt. The discount is amortized using the effective interest method to interest expense over the term of the debt. These loans are subordinated to the Bank debt of the Company.  The remaining balance of $904,000 (net $96,000 discount) is due in 2011.

 
F-18

 

At various times from 2003 to 2005, certain shareholders loaned an aggregate of $814,000 to the Company in exchange for notes bearing interest at an annual rate of 8%. These notes are subordinated to the bank loan of the Company.  The remaining balance of $814,000 is due on demand.

11. Income Taxes
 
The income tax provisions are comprised of the following:
 
   
Dec. 31 2009
   
Dec. 31 2008
 
Current:
           
Federal
  $ -     $ -  
State
    -       -  
Foreign
    128,155       205,089  
    $ 128,155     $ 205,089  
                 
Deferred
               
Federal
  $ (13,764 )   $ 41,690  
State
    -       -  
Foreign
    -       -  
      (13,764 )     41,690  
Total Income Tax Provision
  $ 114,391     $ 246,779  

The components of the net deferred tax asset at December 31 are as follows:

   
2009
   
2008
 
Deferred tax assets:
           
Allowance for doubtful accounts
  $ 15,896     $ 8,389  
Inventory allowances
    125,766       126,109  
Accrued liabilities
    66,473       60,868  
Unicap 263A adjustment
    140,257       121,144  
Net operating loss carryforwards
    1,918,524       2,451,446  
Alternative minimum tax credit carryforwards
    351,619       342,673  
State investment tax credit carryforward
    30,512       30,512  
Foreign tax credit carryforward
    298,635       298,635  
Other foreign tax items
    43,582       43,582  
Foreign asset tax credit carryforward
    (80,368 )     -  
Total deferred tax assets
    2,910,896       3,483,358  
Deferred tax liabilities:
               
Book over tax basis of capital assets
    (1,148,598 )     (1,276,174 )
Other foreign tax items
    (165,099 )     (288,146 )
      1,597,199       1,919,038  
Less: Valuation allowance
    (528,988 )     (902,452 )
Net deferred tax assets
  $ 1,068,211     $ 1,016,586  
 
 
F-19

 

The Company maintains a valuation allowance with respect to deferred tax assets as a result of the uncertainty of ultimate realization. At December 31, 2009, the Company has net operating loss carryforwards of approximately $4,703,000 expiring in various years through 2025. In addition, the Company has approximately $352,000 of alternative minimum tax credits as of December 31, 2009, which have no expiration date.

Income tax provisions differed from the taxes calculated at the statutory federal tax rate as follows:
 
   
Years Ended December 31,
 
   
2009
   
2008
 
Taxes at statutory rate
  $ 392,466     $ 490,397  
State income taxes
    54,026       67,507  
Nondeductible expenses
    17,827       24,277  
Decrease in deferred tax valuation allowance
    (373,464 )     (324,549 )
Foreign taxes and other
    23,536       (10,853 )
Income tax provision
  $ 114,391     $ 246,779  

The Company files tax returns in the U.S. federal and U.K and Mexico foreign tax jurisdictions and various state jurisdictions. The tax years 2006 through 2009 remain open to examination. Our policy is to recognize interest and penalties related to uncertain tax positions in income tax expense. During the twelve months ended December 31, 2009 and 2008, the Company did not recognize expense for interest or penalties, and do not have any amounts accrued at December 31, 2009 and 2008, as the Company does not believe it has taken any uncertain tax positions.

12. Notes Payable Affiliates
 
Items identified as Notes Payable Affiliates in the Company’s Consolidated Balance Sheet as of December 31, 2009 include loans by officers/shareholders to Flexo Universal totaling $659,000.  Items identified as Notes Payable Affiliates in the Company’s Consolidated Balance Sheet as of December 31, 2008 include loans by officers/shareholders to Flexo Universal totaling $858,000.  The remaining balance of $126,000 and $36,000 at December 31, 2009 and 2008, respectively, represents loans from a number of various employees of Flexo Universal.  (See Note 14)

13. Employee Benefit Plan

The Company has a defined contribution plan for substantially all employees. Profit sharing contributions may be made at the discretion of the Board of Directors. Effective January 1, 2006, the Company amended its defined contribution plan.  Under the amended plan, the maximum contribution for the Company is 5% of gross wages. Employer contributions to the plan totaled $99,000 and $118,000 for the years ended December 31, 2009 and 2008, respectively.

 
F-20

 
 
14. Related Party Transactions
 
Stephen M. Merrick is of counsel to a law firm from which we received legal services during the year.  Mr. Merrick is both a director and a shareholder of the Company.  Legal fees incurred with this firm or predecessor, were $130,000 and $174,000 for the years ended December 31, 2009 and 2008, respectively.
 
John H. Schwan, Chairman of the Company, is a principal of Shamrock Packaging and affiliated companies. The Company made purchases of packaging materials from Shamrock of approximately $1,718,000 and $824,000 during the years ended December 31, 2009 and 2008, respectively.

John H. Schwan, Chairman of the Company, is one of the owners of White Horse Production, Inc.  The Company made purchases from White Horse of approximately $44,000 and $46,000 during the years ended December 31, 2009 and 2008, respectively.

John H. Schwan, Chairman of the Company, and Howard W. Schwan, President of the Company, are the brothers of Gary Schwan, one of the owners of Schwan Incorporated which provides building maintenance and remodeling services to the Company.  The Company made purchases from Schwan Incorporated of approximately $27,000 and $142,000 during the years ended December 31, 2009 and 2008, respectively.

During the period from January 2003 to the present, John H. Schwan, Chairman of the Company, and Stephen M. Merrick, Executive Vice President and Chief Financial Officer have made loans to the Company and to Flexo which have outstanding balances, for the Company of $2,356,000 and $2,267,000 (net of discount of $96,000 and $185,000, respectively) and for Flexo of $659,000 and $858,000 as of December 31, 2009 and 2008, respectively.

During 2009 and 2008 interest expense to these individuals on these outstanding loans was $228,000 and $414,000, respectively.  (See Notes 10 and 12)

15. Goodwill
 
Under the provisions of FASB GAAP USA, goodwill is subject to at least annual assessments for impairment by applying a fair-value based test.  FASB GAAP USA also requires that an acquired intangible asset should be separately recognized if the benefit of the intangible asset is obtained through contractual or other legal rights, or if the asset can be sold, licensed, rented or exchanged, regardless of the acquirer’s intent to do so. The Company has no acquired intangible assets other than goodwill.

 
F-21

 

As of December 31, 2009 and 2008 we determined that the fair value of the Company’s interest in goodwill related to Flexo Universal as recorded was not impaired.  The carrying amount of goodwill as of December 31, 2009 and 2008 was $989,000.

16. Commitments
 
Operating Leases

In September of 2005, the Company entered into a lease to rent 16,306 square feet of space in Cary, Illinois from Trinity Assets.  The extended term of this lease expired in September 2009.  The Company’s United Kingdom subsidiary also maintains a lease for office and warehouse space, which expires in 2019.  In February 2008, Flexo Universal entered into a 3-year lease to rent 43,000 square feet of warehouse and office space in Guadalajara, Mexico at the cost of $19,200 per month.  The Company leases office and warehouse equipment under operating leases, which expire on various dates through December 2011.  All of the Company’s lease payments are recognized on a straight-line basis as none of the leases have escalation clauses.

The net lease expense was $511,000 and $445,000 for the years ended December 31, 2009 and 2008, respectively.
 
The future aggregate minimum net lease payments under existing agreements as of December 31, are as follows:

2010
  $ 329,000  
2011
  $ 99,000  
2012
  $ 56,000  
2013
  $ 47,000  
2014
  $ 47,000  
Thereafter
  $ 235,000  
Total
  $ 813,000  

Licenses
 
The Company has certain merchandising license agreements, which are of a one to two year duration that require royalty payments based upon the Company’s net sales of the respective products. The agreements call for guaranteed minimum commitments that are determined on a calendar year basis. Future guaranteed commitments due, as computed on a pro rata basis, as of December 31, are as follows:

2010
  $ 122,750  
2011
  $ 103,000  

 
F-22

 

17. Stockholders’ Equity

Stock Options

The Company has adopted FASB GAAP USA which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated financial statements based on their grant-date fair values.

The Compensation Committee administers the Plans. The exercise price for ISOs cannot be less than the fair market value of the stock subject to the option on the grant date (110% of such fair market value in the case of ISOs granted to a stockholder who owns more than 10% of the Company’s Common Stock). The exercise price of a NQO shall be fixed by the Compensation Committee at whatever price the Committee may determine in good faith. Unless the Committee determines otherwise, options generally have a 10-year term (or five years in the case of ISOs granted to a participant owning more than 10% of the total voting power of the Company’s capital stock). Unless the Committee provides otherwise, options terminate upon the termination of a participant’s employment, except that the participant may exercise an option to the extent it was exercisable on the date of termination for a period of time after termination. Officers, directors, and employees of, and consultants to, the Company or any parent or subsidiary corporation selected by the Committee are eligible to receive options under the Plan. Subject to certain restrictions, the Committee is authorized to designate the number of shares to be covered by each award, the terms of the award, the date on which and the rates at which options or other awards may be exercised, the method of payment, vesting and other terms.

The Company has  applied the Black-Scholes model to value stock-based awards.  That model incorporates various assumptions in the valuation of stock-based awards relating to the risk-free rate of interest to be applied, the estimated dividend yield and expected volatility of our common stock.  The risk-free rate of interest is the U.S. Treasury yield curve for periods within the expected term of the option at the time of grant.  The dividend yield on our common stock is assumed to be zero as we have historically not paid dividends and have no current plans to do so in the future.  The expected volatility is based on historical volatility of the Company’s common stock.

The valuation assumptions we have applied to determine the value of stock-based awards were as follows:

Historical stock price volatility:  The Company used the monthly closing price to calculate historical annual volatility.

Risk-free interest rate:  The Company bases the risk-free interest rate on the rate payable on US treasury securities in effect at the time of the grant.

 
F-23

 

Expected life:  The expected life of the option represents the period of time options are expected to be outstanding.  The Company uses one half of the life of the option.

Dividend yield:  The estimate for dividend yield is 0.0%, because the Company has not historically paid a dividend.

Estimated pre-vesting forfeitures:  When estimating forfeitures, the Company considers historical terminations as well as anticipated retirements.

The Company’s net income for the fiscal year ended December 31, 2009 and 2008 includes approximately $87,000 and $58,000, respectively, of compensation costs related to share-based payments.  As of December 31, 2009, there is $97,000 of unrecognized compensation expense related to non-vested stock option grants.  We expect approximately $72,000 and $25,000 to be recognized during 2010 and 2011, respectively.  No options were exercised during 2009.

On March 19, 1999, the Board of Directors approved for adoption, effective May 6, 1999, the 1999 Stock Option Plan (“Plan”).  The Plan authorizes the grant of options to purchase up to an aggregate of 158,733 shares of the Company’s Common Stock.  As of December 31, 2009, 148,223 shares have been granted under the 1999 Stock Option Plan and were fully vested at the time of grant, 25,786 remain outstanding.
 
On April 12, 2001, the Board of Directors approved for adoption, effective December 27, 2001, the 2001 Stock Option Plan (the “Plan”). The Plan authorizes the grant of options to purchase up to an aggregate of 119,050 shares of the Company’s Common Stock. As of December 31, 2009, 139,958 shares have been granted and were fully vested at the time of grant, 19,453 remain outstanding.  During 2009, 17,858 shares were cancelled.
 
On April 24, 2002, the Board of Directors approved for adoption, effective October 12, 2002, the 2002 Stock Option Plan (“Plan”).  The Plan authorizes the grant of options to purchase up to an aggregate of 142,860 shares of the Company’s Common Stock. As of December 31, 2009, 123,430 shares have been granted and were fully vested at the time of grant, 38,500 remain outstanding.  During 2009, 10,000 shares were cancelled.

On June 22, 2007, the Board of Directors approved for adoption, effective October 1, 2007, the 2007 Incentive Stock Plan (“Plan”). The Plan authorizes the grant of options to purchase up to an aggregate of 150,000 shares of the Company’s Common Stock.  On October 1, 2007, the company issued 74,000 shares under the 2007 Plan.  During 2008, the company issued an additional 77,500 shares under the 2007 Plan.  The fair value of these options was estimated at the date of grant using a Black-Scholes option pricing model with the following weighted average assumptions:  risk-free interest rate of 3.89%; dividend yield of 0%; volatility factor of the expected price of the Company’s stock was 60.67%; and a weighted average expected life of 2.8 years.  Under this plan, 137,000 shares remain outstanding, 84,625 shares are vested and 52,375 are not vested.  During 2009, 12,000 shares were cancelled.

 
F-24

 

2007 Stock Incentive Plan Vesting Schedule
 
 
Years After Grant Date
 
25
 
0.5
 
50
 
1
 
75
 
2
 
100
 
3
 

On April 10, 2009, the Board of Directors approved for adoption, and on June 5, 2009, the shareholders of the Company approved, a 2009 Incentive Stock Plan (“Incentive Stock Plan”).  The Incentive Stock Plan authorizes the issuance of up to 250,000 shares of stock or options to purchase stock of the Company.  No stock or options have been granted under this Plan to date.

The following is a summary of options exercised during the years ended December 31:

   
2009
   
2008
 
         
Intrinsic
         
Intrinsic
 
   
Shares
   
Value
   
Shares
   
Value
 
                         
1999 Plan
    -     $ -       3,976     $ 13,000  
                                 
2001 Plan
    -     $ -       4,381     $ 18,000  
                                 
2002 Plan
    -     $ -       -     $ -  

The following is a summary of the activity in the Company’s stock option plans and other options for the years ended December 31, 2009 and 2008, respectively.

         
Weighted
         
Weighted
 
         
Avg.
         
Avg.
 
   
Dec. 31,
   
Exercise
   
Dec. 31,
   
Exercise
 
   
2009
   
Price
   
2008
   
Price
 
Exercisable, beginning of period
    159,252     $ 2.87       194,370     $ 3.32  
Granted
    -       -       -       -  
Vested
    53,625       3.03       35,750       4.76  
Exercised
    -       -       (8,357 )     2.44  
Cancelled
    (32,608 )     2.26       (62,511 )     5.75  
Exercisable at the end of period
    180,269     $ 3.03       159,252     $ 2.87  

         
Weighted
         
Weighted
 
         
Avg.
         
Avg.
 
   
Dec. 31,
   
Exercise
   
Dec. 31,
   
Exercise
 
   
2009
   
Price
   
2008
   
Price
 
Outstanding, beginning of period
    272,502     $ 2.95       268,370     $ 3.71  
Granted
    -       -       77,500       4.75  
Exercised
    -       -       (8,357 )     2.44  
Cancelled
    (39,858 )     2.42       (65,011 )     5.75  
Outstanding at the end of period
    232,644     $ 3.04       272,502     $ 2.95  

 
F-25

 

At December 31, 2009, available options to grant were 250,000 under the 2009 Stock Incentive Plan.

Significant option groups outstanding at December 31, 2009 and related weighted average price and remaining life information are as follows:

   
Options Outstanding
   
Options Vested
 
Grant Date
 
Shares
   
Wtd Avg
   
Remain. Life
   
Intrinsic Val
   
Shares
   
Wtd Avg
   
Remain. Life
   
Intrinsic Val
 
Mar 2000
    25,786     $ 1.89       0.2     $ 10,057       25,786     $ 1.89       0.2     $ 10,057  
Dec 2001
    5,953     $ 1.47       2.0     $ 4,822       5,953     $ 1.47       2.0     $ 4,822  
Apr 2002
    11,905     $ 2.10       2.3     $ 2,143       11,905     $ 2.10       2.3     $ 2,143  
Dec 2005
    52,000     $ 2.88       6.0     $ -       52,000     $ 2.88       6.0     $ -  
Oct 2007
    64,500     $ 4.76       1.8     $ -       48,375     $ 4.76       1.8     $ -  
Aug 2008
    6,000     $ 6.14       2.6     $ -       3,000     $ 6.14       2.6     $ -  
Oct 2008
    2,500     $ 4.97       2.8     $ -       1,250     $ 4.97       2.8     $ -  
Nov 2008
    64,000     $ 1.84       2.9     $ 28,060       32,000     $ 1.84       2.9     $ 14,030  
                                                                  
TOTAL
    232,644     $ 3.04       2.9     $ 45,081       180,269     $ 3.03       3.0     $ 31,051  

As of December 31, 2009 the aggregate intrinsic value of options in the money, outstanding and exercisable were $45,000 and $31,000, respectively.

Warrants

In February 2003, certain members of company management were issued warrants to purchase 163,000 shares of the Company’s Common Stock at an exercise price of $4.87 per share in consideration of their loaning the company $1,630,000.  On February 8, 2008 those shareholders exercised these options in exchange for a reduction on these notes of $794,000.

In February 2006, certain members of company management were issued warrants, which fully vested immediately, to purchase 303,030 shares of the Company’s Common Stock at an exercise price of $3.30 per share in consideration of their loaning the company $1,000,000.  The fair value of the warrants granted on February 1, 2006, was $443,000 which was estimated at the date of grant using the Black-Scholes pricing model with the following weighted average assumptions:  risk-free interest rate of 3.9%; dividend yield of 0%; volatility factor of the expected price of the Company’s stock was 138.9%; and a weighted average expected life of 5 years. The weighted average fair value of the warrants granted during 2006 was $2.56 per share.

On October 1, 2008, the Company issued warrants to purchase 20,000 shares of common stock of the Company to both John Schwan and Stephen M. Merrick exercisable at the price of $4.80 per share (the market price of the stock on the date of the warrants) in consideration for the personal guarantees by each of up to $2 million in principal amount of the bank debt of the Company.

 
F-26

 

The following is a summary of the activity in the Company’s warrants for the years ended December 2009 and 2008:

         
Weighted
         
Weighted
 
         
Avg.
         
Avg.
 
   
Dec. 31,
   
Exercise
   
Dec. 31,
   
Exercise
 
   
2009
   
Price
   
2008
   
Price
 
Outstanding and Exercisable, beginning of period
    343,030     $ 3.47       466,030     $ 3.85  
Granted
    -       -       40,000       4.80  
Exercised
    -       -       (163,000 )     4.87  
Cancelled
    -       -       -       -  
Outstanding and Exercisable at the end of period
    343,030     $ 3.47       343,030     $ 3.47  

The warrants, outstanding and exercisable as of December 31, 2009 had zero intrinsic value since they were out of the money.

SEDA

On June 6, 2006, we entered into a Standby Equity Distribution Agreement with Cornell Capital pursuant to which we were permitted, at our discretion; periodically sell to Cornell Capital shares of common stock for a total purchase price of up to $5 million.  The commitment of Cornell Capital was for a term commencing on the effective date of our registration statement covering the shares to be sold and expiring after 24 months from that date.  The commitment expired on January 28, 2009.  For each share of common stock purchased under the Standby Equity Distribution Agreement, Cornell Capital agreed to pay one hundred percent (100%) of the lowest volume weighted average price (as quoted by Bloomberg, LP) of our common stock on the NASDAQ Capital Market or other principal market on which our common stock was traded for the five (5) days immediately following the notice date.  Furthermore, Cornell Capital received five percent (5%) of each advance in cash under the Standby Equity Distribution Agreement as an underwriting discount.

On December 28, 2006, we filed a Registration Statement for the registration of 403,500 shares of our common stock.  On January 26, 2007, the Registration Statement was declared effective.  On July 24, 2008, we filed an amended Registration Statement, which was declared effective.  As of December 31, 2008 we had sold an aggregate of 341,864 shares of common stock to Cornell under the SEDA and have received net proceeds from the sale of those shares in the amount of $1,449,000.

18. Earnings Per Share

Basic earnings per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during each period.

Diluted earnings per share is computed by dividing the net income by the weighted average number of shares of common stock and equivalents (stock options and warrants), unless anti-dilutive, during each period.

 
F-27

 

The number of anti-dilutive shares (not included in the determination of earnings on a diluted basis) for the three months ended December 31, 2009, were 468,030 of which 343,030 were represented by warrants and 125,000 were represented by options.  For the twelve months ended December 31, 2009, 479,935 shares were anti-dilutive 343,030 were represented by warrants, 136,905 were represented by options.  The number of anti-dilutive shares (not included in the determination of earnings on a diluted basis) for the three months ended December 31, 2008, were 423,030 of which 343,030 were represented by warrants and 80,000 were represented by options.  For the twelve months ended December 31, 2008, 120,000 shares were anti-dilutive of which 40,000 were represented by warrants and 80,000 were represented by options.

Consolidated Earnings per Share

   
Year Ended December 31,
 
   
2009
   
2008
 
Basic
           
Average shares outstanding:
           
Weighted average number of shares outstanding during the period
    2,765,277       2,763,017  
                 
Earnings:
               
Net income attributable to CTI Industries Corporation
  $ 1,003,140     $ 1,154,133  
                 
Amount for per share Computation
  $ 1,003,140     $ 1,154,133  
                 
Net earnings applicable to Common Shares
  $ 0.36     $ 0.42  
                 
Diluted
               
Average shares outstanding:
    2,765,277       2,763,017  
Weighted averages shares Outstanding Common stock equivalents (options, warrants)
    9,785       135,664  
                 
Weighted average number of shares outstanding during the period
    2,775,062       2,898,681  
                 
Earnings:
               
Net income attributable to CTI Industries Corporation
  $ 1,003,140     $ 1,154,133  
                 
Amount for per share computation
  $ 1,003,140     $ 1,154,133  
                 
Net income applicable to Common Shares
  $ 0.36     $ 0.40  

 
F-28

 

19. Geographic Segment Data

The Company’s operations consist of a business segment which designs, manufactures, and distributes film products. Transfers between geographic areas were primarily at cost plus a standard markup. The Company’s subsidiaries have assets consisting primarily of trade accounts receivable, inventory and machinery and equipment. Sales and selected financial information by geographic area for the years ended December 31, 2009 and 2008, respectively:

   
United States
   
United Kingdom
   
Mexico
   
Consolidated
 
Year ended 12/31/09
                       
Sales to outside customers
  $ 31,873,000     $ 1,971,000     $ 7,451,000     $ 41,295,000  
Total Assets
  $ 23,801,000     $ 733,000     $ 5,861,000     $ 30,395,000  
                                 
   
United States
   
United Kingdom
   
Mexico
   
Consolidated
 
Year ended 12/31/08
                               
Sales to outside customers
  $ 34,701,000     $ 2,762,000     $ 7,518,000     $ 44,981,000  
Total Assets
  $ 24,709,000     $ 740,000     $ 4,539,000     $ 29,988,000  

20. Contingencies

On December 20, 2006, Pliant Corporation filed an action against the Company in the Circuit Court of Cook County, Illinois.  In the action, Pliant claimed that there was due from the Company to Pliant the sum of $245,000 for goods sold and delivered by Pliant to the Company as well as interest on such amount.  On September 30, 2009, this action was settled by payment by the Company to Pliant of the sum of $125,000.

In addition, the Company is also party to certain lawsuits arising in the normal course of business. The ultimate outcome of these matters is unknown, but in the opinion of management, the settlement of these matters is not expected to have a significant effect on the future financial position, cash flows or results of operations of the Company.

21. Subsequent Event

On January 26, 2010, the Company entered into the Sixth Amendment to Loan Agreement with RBS under which the term of the revolving loan facility of the Company with the Bank was extended to April 30, 2010.

 
F-29

 

Schedule II – Valuation and Qualifying Accounts:

The following is a summary of the allowance for doubtful accounts related to accounts receivable for the years ended December 31:
 
   
2009
   
2008
 
Balance at beginning of year
  $ 39,000     $ 312,000  
Charged to expenses
  $ 65,000     $ 139,000  
Uncollectible accounts written off
  $ (47,000 )   $ (412,000 )
Balance at end of year
  $ 57,000     $ 39,000  

The following is a summary of the allowance for excess inventory for the years ended December 31:
 
   
2009
   
2008
 
Balance at beginning of year
  $ 429,000     $ 383,000  
Charged to expenses
  $ 25,000     $ 150,000  
Obsolete inventory written off
  $ (112,000 )   $ (104,000 )
Balance at end of year
  $ 342,000     $ 429,000  

The following is a summary of property and equipment and the related accounts of accumulated depreciation for the years ended December 31:

   
2009
   
2008
 
Cost Basis
           
Balance at beginning of year
  $ 31,253,000     $ 29,696,000  
Additions
  $ 835,000     $ 1,557,000  
Disposals
  $ -     $ -  
Balance at end of year
  $ 32,088,000     $ 31,253,000  
                 
Accumulated depreciation
               
Balance at beginning of year
  $ 20,677,000     $ 19,600,000  
Depreciation
  $ 1,878,000     $ 1,077,000  
Disposals
  $ -     $ -  
Balance at end of year
  $ 22,555,000     $ 20,677,000  

 
F-30